WO2022135521A1 - Medical data processing method and monitoring equipment - Google Patents
Medical data processing method and monitoring equipment Download PDFInfo
- Publication number
- WO2022135521A1 WO2022135521A1 PCT/CN2021/140825 CN2021140825W WO2022135521A1 WO 2022135521 A1 WO2022135521 A1 WO 2022135521A1 CN 2021140825 W CN2021140825 W CN 2021140825W WO 2022135521 A1 WO2022135521 A1 WO 2022135521A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- treatment
- information
- related data
- measure
- display
- Prior art date
Links
- 238000003672 processing method Methods 0.000 title claims abstract description 6
- 238000012544 monitoring process Methods 0.000 title abstract description 5
- 238000011282 treatment Methods 0.000 claims abstract description 569
- 230000009471 action Effects 0.000 claims abstract description 13
- 238000000034 method Methods 0.000 claims description 47
- 230000008569 process Effects 0.000 claims description 23
- 229940079593 drug Drugs 0.000 claims description 10
- 239000003814 drug Substances 0.000 claims description 10
- 238000012806 monitoring device Methods 0.000 claims description 10
- 238000004590 computer program Methods 0.000 claims description 7
- 238000012545 processing Methods 0.000 claims description 6
- 230000001225 therapeutic effect Effects 0.000 claims description 6
- 238000010876 biochemical test Methods 0.000 claims description 4
- 238000003745 diagnosis Methods 0.000 claims description 4
- 230000004044 response Effects 0.000 claims description 4
- 206010040047 Sepsis Diseases 0.000 abstract description 14
- 201000010099 disease Diseases 0.000 abstract description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 6
- 208000024891 symptom Diseases 0.000 abstract description 4
- 230000000474 nursing effect Effects 0.000 abstract description 3
- 238000010586 diagram Methods 0.000 description 18
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 11
- GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 description 11
- 102000002852 Vasopressins Human genes 0.000 description 11
- 108010004977 Vasopressins Proteins 0.000 description 11
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 description 11
- 229960002748 norepinephrine Drugs 0.000 description 11
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 11
- 229960003726 vasopressin Drugs 0.000 description 11
- 238000002560 therapeutic procedure Methods 0.000 description 10
- 230000006870 function Effects 0.000 description 6
- 238000009098 adjuvant therapy Methods 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 206010040070 Septic Shock Diseases 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 238000009534 blood test Methods 0.000 description 4
- 230000036303 septic shock Effects 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 230000004872 arterial blood pressure Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000003319 supportive effect Effects 0.000 description 2
- 230000002227 vasoactive effect Effects 0.000 description 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- 206010058558 Hypoperfusion Diseases 0.000 description 1
- 206010021137 Hypovolaemia Diseases 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940124572 antihypotensive agent Drugs 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 238000009640 blood culture Methods 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000010801 machine learning Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000009120 supportive therapy Methods 0.000 description 1
- 238000002627 tracheal intubation Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000002550 vasoactive agent Substances 0.000 description 1
- 239000005526 vasoconstrictor agent Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
Definitions
- the present application relates to the field of medical technology, and more particularly, to a method for processing medical data and a monitoring device.
- clinicians need to analyze whether the treatment measures are appropriate and timely from the aspects of various physical signs of the patient, the treatment plan itself, the timing of treatment intervention, and the sequence of treatment behaviors.
- clinicians can obtain data and information from the electronic medical record information system when analyzing treatment measures.
- the data and information that clinicians need to obtain will change with the change of treatment methods.
- What data needs to be stored in the electronic medical record information system is the early stage Well defined, it is difficult to modify the data stored in the electronic medical record information system.
- a method for processing medical data comprising:
- the treatment measure set including multiple pieces of treatment measure information
- the matching information indicating that the treatment-related data is consistent with at least one piece of treatment-measure information in the treatment-measure set match or not match;
- the matching information determine the execution state of the treatment measure information in the treatment measure set, where the execution state indicates: whether the treatment measure information is executed and the execution time;
- a monitoring device comprising:
- a memory storing a preset treatment measure set corresponding to the treatment process carried out on the target object, the treatment measure set including a plurality of pieces of treatment measure information;
- a processor configured to perform the following steps:
- the treatment-related data determine the execution state of the treatment measure information in the treatment measure set, where the execution state indicates: whether the treatment measure information is executed and the execution time;
- the execution status of the treatment measure information is displayed through the display.
- a non-volatile computer-readable storage medium on which a computer program is stored, and when the computer program is executed by a processor, implements the steps of the medical data processing method described in any of the embodiments herein .
- FIG. 1 is a structural block diagram of a monitoring device provided by an embodiment of the present invention.
- FIG. 2 is a schematic diagram of a first display interface provided by an embodiment of the present invention.
- FIG. 3 is an exemplary diagram of a first display interface provided by an embodiment of the present invention.
- FIG. 4 is a schematic diagram of a third display interface provided by an embodiment of the present invention.
- FIG. 5 is an exemplary diagram of a third display interface provided by an embodiment of the present invention.
- FIG. 6 is a schematic diagram of a second display interface provided by an embodiment of the present invention.
- FIG. 7 is an exemplary diagram of a second display interface provided by an embodiment of the present invention.
- FIG. 8 is another exemplary diagram of a second display interface provided by an embodiment of the present invention.
- FIG. 9 is a flowchart of a method for processing medical data provided by an embodiment of the present invention.
- connection and “connection” mentioned in this application, unless otherwise specified, include both direct and indirect connections (connections).
- FIG. 1 shows a structural block diagram of a monitoring device provided by an embodiment of the present invention.
- the monitoring device at least includes: a memory 100, a display 200, and a processor 300;
- the memory 100 stores a preset treatment measure set corresponding to the treatment process performed on the target object, and the treatment measure set includes a plurality of pieces of treatment measure information.
- the set of treatment measures stored in the memory 100 at least includes: the treatment measures information in the treatment guide corresponding to the treatment process carried out on the target object, for example: if the target object is a sepsis patient, the memory 100 stores The treatment set contains at least: treatment information in the sepsis guidelines and treatment information in other treatment guidelines related to sepsis.
- the treatment action information of the treatment action set stored in the memory 100 may be derived from treatment guidelines of different versions.
- the first treatment measure set and the second treatment measure set may correspond to treatment guidelines issued at different times, and at least part of the treatment measure information in the first treatment measure set and the second treatment measure set is different.
- the difference here may include different types of treatment measures, and may also include different parameters of the same treatment measure.
- the multiple pieces of treatment measure information in the treatment measure set can also be set with a preset execution order, and the treatment measure information can be combined according to the preset execution order to form a treatment measure sequence, and the treatment measure set including the treatment measure sequence can also be called a cluster. chemotherapy treatment set.
- the difference between different treatment measure sets is not only reflected in the types of treatment measures or treatment parameters described above, but also in the preset execution order of the treatment measures.
- the processor 300 is configured to perform the following steps: obtaining a treatment measure set from the memory 100, and displaying at least part of the treatment measure information of the obtained treatment measure set through the display 200; obtaining treatment of the target object sequentially generated during the treatment process Relevant data; according to the treatment-related data, determine the execution state of the treatment measure information in the treatment measure set, and the execution state indicates: whether the treatment measure information is executed and the execution time; the display 200 displays the execution state of the treatment measure information.
- the treatment measure information in the treatment measure set obtained by the processor 300 from the memory 100 may be directly derived from a specified version of the treatment guideline, or may be derived from the user's adjustment to the treatment measure information in the treatment guideline Formed custom treatment measures information. That is to say, the treatment measure set acquired by the processor 300 includes: the treatment measure information directly specified in the treatment guideline of the specified version, and/or the treatment formed after the user modifies the treatment measure information specified in the treatment guideline Action information.
- the adjustment of the treatment measure information by the user is usually to adjust the parameters or sequence of the treatment measures involved in the treatment measure information.
- the operating user can set the content in the treatment measure set, but the operating user needs to have the corresponding operating authority
- the processor 300 is configured to: according to the password information and/or user identity information submitted by the operating user, to The operation user performs identity verification to determine whether the operation user has the operation authority of the treatment measure set; if it is determined that the operation user has the operation authority of the treatment measure set, the content of the treatment measure set is set in response to the operation of the operation user.
- the display 200 is controlled to display at least part of the treatment measure set, that is, the display 200 is controlled to display part of the treatment measure information of the treatment measure set.
- the processor 300 may control the display 200 to provide a plurality of display interfaces, wherein part of the treatment measure information of the treatment measure set is displayed in the first display interface.
- FIG. 2 shows multiple display interfaces that are not displayed on the same screen, in other embodiments not shown, the processor 300 may control the display 300 to provide multiple display interfaces that output on the same screen, and each display interface is the display 300 respectively. a display part of .
- the first display interface or the second and third display interfaces it includes not only a situation where multiple display interfaces are displayed on the same screen at least partially, but also a situation where each display interface is not displayed on the same screen.
- the processor 300 obtains treatment-related data of the target object sequentially generated during the treatment process, and the treatment-related data at least includes: medication events, actually performed treatment measures, the diagnosis results of the target object, and the target object Any one or more of the biochemical test results, such as: obtaining the ventilator intubation operation from the doctor's record, the blood drawing operation from the nurse, the drug administration data from the infusion system, from the biochemical test system (such as the LTS system) The biochemical test indicators of the patient, and the treatment-related data such as a diagnosis result from the doctor's order system.
- the treatment-related data can also be a unique code related to the treatment measures information in the specified version of the treatment guideline, for example: the code "SSC16-Vasoactive-01” corresponds to the specific details of the vasoactive drugs chapter in the sepsis guideline.
- the recommendation clause "recommends norepinephrine as the first-choice vasopressor (strong recommendation, moderate-quality evidence).”
- the treatment-related data obtained by the processor 300 may come from a number of different sources.
- various kinds of treatment-related data may be obtained first, and the obtained plurality of kinds of relevant data are respectively used for the subsequent execution state analysis of the treatment measure information.
- the processor 300 after obtaining the treatment-related data, performs time synchronization on all the treatment-related data to ensure that all the obtained treatment-related data are consistent in time in the time dimension.
- the specific implementation may be as follows: the processor 300 obtains the actual generation time of the treatment-related data, so as to ensure that all the treatment-related data are consistent in time in the time dimension. For example: Suppose that for the treatment-related data of blood test results, the medical staff draws blood on the target object at 10:00 in the morning, and the blood test results are obtained at 3:00 p.m. (the index indicated by the blood test results is the target object in the morning. 10:00), the actual time for obtaining the blood test results is 10:00 a.m. instead of 3:00 p.m.
- the processor 300 is further configured to extract key information in the treatment-related data, where the key information can be used to match the treatment measure information. For example: extract the key data of "septic shock", “crystalloid fluid” and “initial resuscitation fluid” from one of the treatment-related data in "For patients with septic shock, choose crystalloid as the initial resuscitation fluid", another example: from “ Use norepinephrine combined with vasopressin 0.02U/min to maintain the target mean blood pressure" in the treatment-related data, extract “norepinephrine”, “combination”, “vasopressin”, “0.02U” /min” and “target mean pressure” key information, where “0.02U/min” is associated with “vasopressin”.
- the processor 300 determines, according to the treatment-related data, the execution state of the treatment measure information in the treatment measure set obtained by the processor 300, where the execution state may be used to indicate the treatment measure information Whether it was performed and when the treatment was performed information.
- the processor 300 uses the treatment-related data to match the treatment-measure information in the treatment-measure set, and determines whether the treatment-related data matches one or more pieces of treatment-measure information. The matching result marks the treatment-related data to indicate to which treatment measure information the treatment-related data matches.
- the processor 300 can also judge whether the treatment-related data does not match some or any of the treatment measures information, and mark the treatment-related data according to the judgment result to indicate which treatment-related data is associated with information on treatment measures.
- treatment-related data may be provided with a flag indicating "meet" or "non-compliance.”
- the treatment-related markers can be understood as matching information between treatment measure information and treatment-related data. Through the matching information of the treatment-related data, it can be determined which treatment measure information in the treatment measure set has been executed, and then based on the execution time of the treatment-related data, the execution status of the corresponding treatment measure information can be obtained.
- Example Using key information extracted from the treatment-related data "Use of norepinephrine in combination with vasopressin 0.02 U/min to maintain target mean blood pressure" in conjunction with the provisions of the vasoactive drugs chapter of the sepsis guidelines "2.
- MAP mean arterial pressure
- the first display interface displays a plurality of pieces of treatment measure information (the treatment measure information in FIG. 2 ). 1 to 4), you can mark " ⁇ " in the rectangular box to the left of the treatment information to indicate that the treatment information is executed (such as treatment information 1 is executed), and display the treatment information on the right of the treatment information. execution time.
- the content shown in FIG. 2 is only for illustration, and other methods may also be used to indicate that the treatment measure information is executed (for example, the treatment measure information that has been executed is bold and black, or, the treatment measure information that has been executed has been executed.
- the rectangle box to the left of the treatment measure information is filled with black), and the execution time of the treatment measure information may also be represented in other ways.
- the multiple pieces of treatment measure information included in the treatment measure set may also be set with an execution sequence, and the treatment action information executed according to the preset execution sequence may form a treatment action sequence.
- the processor 300 may be further, but not necessarily, configured to determine whether the execution order of the executed treatment measures in the treatment measure set conforms to a preset execution order.
- the processor 300 is not only used to determine whether the treatment-related data matches the treatment-measure information in the treatment-measure set, but also, after identifying the treatment-related data matching the treatment-measure information, further determine the generation time of each piece of treatment-related data (ie, Whether the order of execution time of the corresponding treatment measure information) matches the preset execution order of the corresponding treatment measure information.
- the processor 300 uses the treatment-related data to match the treatment measure information in the treatment measure set, not only to determine whether the treatment-related data matches one or more pieces of treatment measure information, but also Determine whether the time corresponding to the treatment-related data matches the preset execution order of the treatment measure information, and mark the treatment-related data according to the result of matching to indicate the matching of the treatment-related data with the treatment measure information and its execution order result.
- treatment-related data may be provided with tags indicating "content and sequence,” “content but not sequence,” or “not conforming.”
- the non-conformity here means that no treatment measure information matching the treatment-related data is found in the treatment measure set, and accordingly, there is no need to analyze and judge the execution order.
- the treatment-related markers can be understood as matching information between treatment measure information and treatment-related data. Through the matching information of the treatment-related data, it is possible to determine which treatment-measure information in the treatment-measure set has been executed and whether it is executed in a preset execution order, and then obtain the execution status of the corresponding treatment-measure information based on the execution time of the treatment-related data.
- the processor 300 may extract key information from the treatment-related data, and then analyze and determine whether the extracted key information matches the treatment measure information in the treatment measure set;
- the treatment-measure information of the measure set is trained, so that in the obtained treatment-related data, the treatment-related data belonging to the treatment-measure information is directly identified based on machine learning, and the execution state of the treatment-measure information is determined accordingly.
- the execution state in which the processor 300 obtains the treatment measure information according to the treatment-related data may not be limited to the above two embodiments, and other equivalent embodiments are also within the scope of the intended protection of the present application.
- the set of treatment measures obtained by the processor 300 includes at least a set of bundled treatment measures associated with a specific condition, such as a set of bundled treatment measures associated with sepsis.
- a bundle of treatment measures associated with sepsis includes information on a series of treatment measures to be executed in an orderly manner, that is, a sequence of treatment measures.
- the processor 300 is further configured to: display at least a part of the bundle treatment measure set through the display 200; mark the information of the treatment measures that have been performed in the bundle therapy measure set according to the treatment-related data, and display the execution of the performed treatment measure set time.
- Fig. 3 is an example diagram of the first display interface. It should be noted that the "bundle therapy" interface in Fig.
- the processor 300 displays a set of bundled treatment measures that need to be completed within 3 hours in the first display interface; as shown in Figure 3, when “monitoring blood lactate level” and “obtaining blood culture specimens before antibiotics are determined” through treatment-related data ” If these two pieces of treatment measure information are executed, the box on the left side of the executed treatment measure information will mark “ ⁇ ” to indicate that the treatment measure information is executed, and the execution of the treatment measure information will be displayed on the right side of the executed treatment measure information. time. It should be noted that the operating user can manually input the execution status of a certain treatment measure information.
- the operating user can manually mark " ⁇ " in the box on the left side of a certain treatment measure information. At this time, the user can manually Enter or automatically obtain the execution time of treatment information and display it. In the embodiment not shown, on the basis of the execution state shown in FIG. 3 , the processor may further determine whether the information of the treatment measures marked with “ ⁇ ” is executed in sequence.
- the displayed treatment information in the bundled treatment set can come from different time versions of the bundled treatment set, that is, the operating user can select the treatment to be displayed from the bundled treatment set of different time versions.
- Action information In some specific embodiments, the bundled therapy measure set includes a first bundled therapy measure set and a second bundled therapy measure set of different time versions, and the first bundled therapy measure set and the second bundled therapy measure set have at least Some of the different treatments available.
- the processor 300 is further configured to: receive the selection of the first bundle treatment measure set and the second bundle treatment measure set by the operating user, and display the selection result selected by the operating user on the display 200 .
- the set of therapeutic measures also includes a set of adjuvant therapy measures associated with a particular condition, such as a set of adjuvant therapy measures associated with sepsis.
- the adjuvant therapy measure set may contain a sequence of therapy measures, or may only contain multiple pieces of therapy measure information without a preset execution sequence.
- the processor 300 is further configured to: display at least a part of the auxiliary treatment measure set through the display 200, and identify the execution status and execution time of the executed treatment measure information according to the treatment-related data.
- the treatment measure information included in the auxiliary treatment measure set has no preset execution order, and at least part of the treatment measure information (treatment measure information 1 to 4) in the auxiliary treatment measure set is displayed in the third display interface, Regarding how to identify the execution state and execution time of the treatment measure information that has been executed in the third display interface, reference may be made to the content shown in FIG. 2 above, which will not be repeated here.
- the treatment measure information in the adjuvant treatment measures set may be treatment suggestions, as shown in the example diagram of the third display interface shown in FIG. 5 , the “supportive care” in FIG. 5
- the interface is the third display interface.
- several treatment suggestions that is, the treatment measures information in the adjuvant treatment measures
- the contents of the several treatment suggestions are shown in Figure 5. Among them, Regarding how to identify the execution status and execution time of the executed treatment measure information in FIG. 5 , reference may be made to the content shown in FIG. 3 above, which will not be repeated here.
- the processor 300 is further configured to: determine matching information between each treatment-related data and the treatment measure information in the treatment measure set, and store the matching information in the memory 100, the matching information indicating: the treatment The relevant data matches at least one piece of treatment measure information in the treatment measure set, or the treatment-related data does not match any piece of treatment measure information in the treatment measure set.
- the matching information of a certain treatment-related data it is possible to intuitively know whether the treatment process corresponding to the treatment-related data conforms to the treatment measure information corresponding to the treatment-related data. That is to say, through the matching information, one can intuitively understand the treatment process. Whether to follow the treatment measure information in the treatment measure set; when the treatment process corresponding to a certain treatment-related data does not conform to the corresponding treatment measure information, you can intuitively understand the difference between the treatment-related data and the treatment measure information through the matching information.
- the processor 300 is further configured to: display the treatment-related data, or display the treatment-related data and the matching information corresponding to the treatment-related data, through the display 200 according to the chronological order in which the treatment-related data is generated.
- FIG. 6 is a schematic diagram of the second display interface.
- the second display interface includes a first display area and a second display area.
- treatment-related data is displayed in the second display area of the second display interface. , or display treatment-related data and matching information corresponding to the treatment-related data.
- the processor 300 is configured to: obtain the physiological sign data of the target object generated in sequence during the treatment process, for example, obtain the physiological sign data (heart rate value, blood oxygen saturation) of the target object from the monitoring device Physiological sign data such as degree and Hb); generate display information corresponding to the physiological sign data, and the display information includes at least waveform display information; display the display information corresponding to the physiological sign data through the first display area of the display 200; display the treatment in the second display area related data, or display treatment-related data and matching information corresponding to the treatment-related data.
- physiological sign data heart rate value, blood oxygen saturation
- the second display interface includes a first display area and a second display area, and the display information corresponding to the physiological sign data of the target object is displayed in the first display area; in the second display area
- the display area displays the treatment-related data, or displays the treatment-related data and matching information corresponding to the treatment-related data.
- the treatment-related data acquired by the processor 300 are sequentially generated during the treatment process, and the acquired physiological sign data are also sequentially generated.
- a time axis is set on the interface to display physiological sign data and treatment-related data at different times.
- the first display area includes a time axis and a movable cursor, and the first display area displays the sign value of the physiological sign data and the overview information of the treatment-related data corresponding to the time pointed by the cursor in the time axis, And, in the second display area, the treatment-related data corresponding to the time pointed by the cursor in the time axis is highlighted, or the treatment-related data and the matching information corresponding to the treatment-related data are highlighted.
- a treatment event icon can be set in the time axis displayed in the first display area, and the treatment event icon indicates the treatment event icon.
- Treatment-related data exists at the time in the timeline.
- a treatment event icon for indicating the existence of treatment-related data is displayed on the time axis of the first display area, and overview information of the treatment-related data corresponding to the treatment event icon pointed to by the cursor is displayed on the time axis , and the treatment-related data corresponding to the treatment event icon pointed to by the cursor, or the matching information corresponding to the treatment-related data and the treatment-related data are highlighted in the second display area.
- the waveform display information of the physiological sign data of the target object is displayed in the first display area of the second display interface, and the treatment-related information of the target object is displayed in the second display area. data.
- the "process tracking" interface is the second display interface
- 501 is the above-mentioned movable cursor
- 502 is the physical sign data corresponding to the time pointed by the cursor
- 503 is the medication event (showing a section of Medication overview in time), when there is a medication event at the time pointed by the cursor, the medication details will be displayed
- 504 is the above-mentioned treatment event icon (the treatment event icon can be represented by a filled black triangle or other forms)
- 505 It is the treatment-related data corresponding to the treatment event icon (such as the actual treatment measures and execution time).
- MAP mean arterial pressure
- ScvO2 central venous oxygen saturation
- positions of the first display area and the second display area and the display positions of the vital values in the second display interface shown in FIG. 7 are only used for illustration.
- the positions of the first display area and the second display area and the display positions of the vital values are set, which are not specifically limited here.
- the second display area only displays the treatment-related data corresponding to the treatment event icon; about the second display area, the treatment-related data corresponding to the treatment event icon and the treatment-related data corresponding to the treatment event icon are displayed.
- the example diagram shown in Figure 8 For an example of matching information of , see the example diagram shown in Figure 8 below.
- the waveform display information of the physiological sign data of the target object is displayed in the first display area of the second display interface, and the treatment-related information of the target object is displayed in the second display area.
- Matching information corresponding to data and treatment-related data is the "process tracking" interface is the second display interface
- 501 is the above-mentioned movable cursor
- 505-1 is the treatment-related data (such as the executed treatment measures) corresponding to the treatment event icon
- Matching information corresponding to the treatment-related data which can be used to indicate whether the treatment-related data conforms to the treatment measure information in the treatment measure set.
- the symbol “ ⁇ ” indicates that it conforms to the treatment measure information in the treatment measure set, and the symbol “ ⁇ ” indicates Not conforming to the treatment measure information in the treatment measure set (at the same time, showing which treatment measure information is inconsistent with or having a difference, and marking the difference content in a manner such as blackening and/or bolding).
- early fluid Pulse therapy should be infused with crystalloids at a dose of at least 30mL/kg.
- This treatment measures information on the treatment measures at this time, the content of "30mL/kg” is blackened to mark the difference with the treatment measures information. Difference content.
- the treatment-related data displayed in the second display area in FIG. 8 may be clinical daily words.
- matching information of whether the treatment measure information corresponding to the treatment-related data is executed according to the preset execution order may be further displayed in the area 505 - 1 .
- whether the treatment-related data in the area 505-1 conforms to the preset execution order may be directly marked. For example, if it conforms to the preset execution order, it will display "in accordance with the execution order", and if it deviates from the preset execution order, it will display "execution order is wrong", and optionally provide the order in which the corresponding treatment-related data should appear relative to other treatment-related data. , or provide the order in which the treatment measures information corresponding to the treatment-related data should be executed, so as to assist the user to quickly understand which link in the current treatment of the target object is wrong.
- the processor 300 may collect statistics on the execution of the treatment measure information in the treatment measure set within a preset time period, and may directly prompt the user about the execution status, or may prompt the user of the treatment measure set that must be executed in sequence. Information about treatment measures that are often overlooked or information about treatment measures that are often executed in an incorrect order, or can also prompt the user for information about treatment measures that are most frequently used in a concentrated set of treatment measures that represent treatment recommendations. These analysis of treatment-related data can improve the intelligence of the use of monitoring equipment.
- sorting order of the first display interface, the second display interface and the third display interface shown in FIG. 2 to FIG. 8 is only for example, and can also be adjusted according to actual conditions.
- the relevant treatment and nursing measures can be quickly, completely and accurately recorded.
- Users can customize the version of the guide they refer to, so as to improve users' understanding of diseases represented by sepsis. Flexibility for orderly tracking management.
- a method for processing medical data is also disclosed in some embodiments of the present invention.
- FIG. 9 a flowchart of a medical data processing method provided by an embodiment of the present invention is shown, and the processing method includes:
- Step S901 Acquire a preset treatment measure set corresponding to the treatment process performed on the target object. It should be noted that the treatment measure set includes multiple pieces of treatment measure information.
- the treatment measure set includes: treatment measure information in a prescribed version of the treatment guideline, and/or user-defined treatment measure information formed after the manipulation user adjusts the treatment measure information in the treatment guideline.
- the operating user before setting the content of the therapeutic measure set, determines whether the operating user has the operating authority of the therapeutic measure set according to the password information and/or user identity information submitted by the operating user; if the operating user has the therapeutic measure
- the operation authority of the set in response to the operation of the operation user, sets the content of the treatment measure set.
- Step S902 Acquire the treatment-related data of the target object sequentially generated in the treatment process.
- the treatment-related data includes at least one of the following: medication events, actually performed treatment measures, diagnostic results of the target subject, and biochemical examination results of the target subject.
- Step S903 Determine matching information between each treatment-related data and the treatment measure information in the treatment measure set.
- the matching information indicates that the treatment-related data matches or does not match at least one piece of treatment measure information in the treatment measure set.
- the actual generation time of the treatment-related data is obtained before determining the match information between each treatment-related data and the treatment measure information in the treatment measure set.
- key information in the treatment-related data is extracted prior to determining matching information between each treatment-related data and treatment-measure information in the treatment-measure set.
- Step S904 According to the matching information between the treatment-related data and the treatment measure information, determine the execution state of the treatment measure information in the treatment measure set.
- the execution status indicates: whether the treatment measure information is executed and the execution time.
- the execution status may further include the execution order of the treatment measure information.
- Step S905 Display at least part of the treatment measure information in the treatment measure set, and the execution status of at least part of the displayed treatment measure information.
- the treatment measure set further includes a preset execution order of multiple pieces of treatment measure information; the matching information is further used to indicate: treatment-related data matched with at least one piece of treatment measure information and the preset execution order of the treatment measure information Whether the execution sequence matches or does not match, the execution status is also used to indicate whether the treatment measures information is executed in sequence.
- the physiological sign information of the target object generated in sequence during the treatment process is obtained; display information corresponding to the physiological sign data is generated, and the display information at least includes waveform display information; A display area displays display information corresponding to the physiological sign data; a second display area in the second display interface displays treatment-related data and matching information corresponding to the treatment-related data.
- the first display area includes a time axis and a movable cursor, and the first display area displays the sign value of the physiological sign data and the overview information of the treatment-related data corresponding to the time pointed by the cursor in the time axis, and the treatment-related data corresponding to the time pointed by the cursor in the time axis and the matching information corresponding to the treatment-related data are highlighted in the second display area.
- the program can also be stored in a server, another computer, a magnetic disk, an optical disk, a flash disk or a mobile hard disk and other storage media, and saved by downloading or copying All or part of the functions in the above embodiments can be implemented when the program in the memory is executed by the processor.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Abstract
A medical data processing method and monitoring equipment. For a certain disease or symptom, relevant treatment and nursing measures and actions taken can be completely, quickly and accurately recorded. In particular, for application scenarios of sepsis, a user can customize the version of a guide referenced, thereby improving the flexibility of the user to track and manage the diseases represented by sepsis in an orderly manner.
Description
本发明要求于2020年12月25日提交中国专利局、申请号为202011563790.6、发明名称为“一种监护设备”的中国专利申请的优先权,其全部内容通过引用结合在本申请中。The present invention claims the priority of the Chinese patent application with the application number 202011563790.6 and the invention name "a monitoring device" filed with the China Patent Office on December 25, 2020, the entire contents of which are incorporated in this application by reference.
本申请涉及医疗技术领域,更具体的说是涉及一种医疗数据的处理方法及监护设备。The present application relates to the field of medical technology, and more particularly, to a method for processing medical data and a monitoring device.
在治疗某些疾病或症状时,临床医生需要从病人的各类体征指标、治疗方案本身、治疗介入时机和治疗行为先后顺序等多个方面来分析治疗措施是否合适与及时。When treating certain diseases or symptoms, clinicians need to analyze whether the treatment measures are appropriate and timely from the aspects of various physical signs of the patient, the treatment plan itself, the timing of treatment intervention, and the sequence of treatment behaviors.
目前临床医生在分析治疗措施时,可以从电子病历信息系统获取数据和信息,但是临床医生所要获取的数据和信息会随着治疗方法的变化而变化,而电子病历信息系统需要存储哪些数据是前期定义好的,修改电子病历信息系统所需要存储的数据的难度较高。At present, clinicians can obtain data and information from the electronic medical record information system when analyzing treatment measures. However, the data and information that clinicians need to obtain will change with the change of treatment methods. What data needs to be stored in the electronic medical record information system is the early stage Well defined, it is difficult to modify the data stored in the electronic medical record information system.
在此种情况下,临床医生只能从护理记录和医嘱系统获取零散的数据,再凭借自身对于治疗过程的记忆来复原整个治疗过程的细节,最后再用于分析,此种方式不方便临床医生总结治疗经验也不利于评估治疗效果。In this case, clinicians can only obtain scattered data from the nursing record and the doctor's order system, and then rely on their own memory of the treatment process to restore the details of the entire treatment process, and finally use it for analysis, which is inconvenient for clinicians. Summarizing treatment experience is also not conducive to evaluating treatment effects.
发明内容SUMMARY OF THE INVENTION
根据第一方面,提供一种医疗数据的处理方法,所述方法包括:According to a first aspect, a method for processing medical data is provided, the method comprising:
获取与对目标对象开展的治疗过程对应的预设的治疗措施集,所述治疗措施集包括多条治疗措施信息;acquiring a preset treatment measure set corresponding to the treatment process performed on the target object, the treatment measure set including multiple pieces of treatment measure information;
获取在治疗过程中依序产生的所述目标对象的治疗相关数据;Obtain the treatment-related data of the target object sequentially generated during the treatment;
确定每一所述治疗相关数据与所述治疗措施集中的所述治疗措施信息之间的匹配信息,所述匹配信息指示:所述治疗相关数据与所述治疗措施集中的至少一条治疗措施信息相匹配或不匹配;determining matching information between each of the treatment-related data and the treatment-measure information in the treatment-measure set, the matching information indicating that the treatment-related data is consistent with at least one piece of treatment-measure information in the treatment-measure set match or not match;
根据所述匹配信息,确定所述治疗措施集中所述治疗措施信息的执行状态,所述执行状态指示:所述治疗措施信息是否被执行以及执行时间;According to the matching information, determine the execution state of the treatment measure information in the treatment measure set, where the execution state indicates: whether the treatment measure information is executed and the execution time;
显示所述治疗措施集的至少部分治疗措施信息及其执行状态。Displaying at least part of the treatment measure information and its execution status of the treatment measure set.
根据第二方面,提供一种监护设备,所述设备包括:According to a second aspect, a monitoring device is provided, the device comprising:
存储器,存储与对目标对象开展的治疗过程对应的预设的治疗措施集,所述治疗措施集包括多条治疗措施信息;a memory, storing a preset treatment measure set corresponding to the treatment process carried out on the target object, the treatment measure set including a plurality of pieces of treatment measure information;
显示器;monitor;
处理器,所述处理器配置用于执行下列步骤:a processor configured to perform the following steps:
从所述存储器中获取所述治疗措施集,并通过所述显示器显示所获取的所述治疗措施集的至少部分治疗措施信息;Acquire the treatment measure set from the memory, and display at least part of the treatment measure information of the obtained treatment measure set through the display;
获取在治疗过程中依序产生的所述目标对象的治疗相关数据;Obtain the treatment-related data of the target object sequentially generated during the treatment;
根据所述治疗相关数据,确定所述治疗措施集中的所述治疗措施信息的执行状态,所述执行状态指示:所述治疗措施信息是否被执行以及执行时间;According to the treatment-related data, determine the execution state of the treatment measure information in the treatment measure set, where the execution state indicates: whether the treatment measure information is executed and the execution time;
通过所述显示器显示所述治疗措施信息的执行状态。The execution status of the treatment measure information is displayed through the display.
根据第三方面,提供一种非易失性计算机可读存储介质,其上存储有计算机程序,所述计算机程序被处理器执行时实现本文任一实施例所述的医疗数据的处理方法的步骤。According to a third aspect, a non-volatile computer-readable storage medium is provided, on which a computer program is stored, and when the computer program is executed by a processor, implements the steps of the medical data processing method described in any of the embodiments herein .
图1为本发明实施例提供的一种监护设备的结构框图;1 is a structural block diagram of a monitoring device provided by an embodiment of the present invention;
图2为本发明实施例提供的第一显示界面的示意图;2 is a schematic diagram of a first display interface provided by an embodiment of the present invention;
图3为本发明实施例提供的第一显示界面的示例图;3 is an exemplary diagram of a first display interface provided by an embodiment of the present invention;
图4为本发明实施例提供的第三显示界面的示意图;4 is a schematic diagram of a third display interface provided by an embodiment of the present invention;
图5为本发明实施例提供的第三显示界面的示例图;FIG. 5 is an exemplary diagram of a third display interface provided by an embodiment of the present invention;
图6为本发明实施例提供的第二显示界面的示意图;6 is a schematic diagram of a second display interface provided by an embodiment of the present invention;
图7为本发明实施例提供的第二显示界面的示例图;FIG. 7 is an exemplary diagram of a second display interface provided by an embodiment of the present invention;
图8为本发明实施例提供的第二显示界面的另一示例图;8 is another exemplary diagram of a second display interface provided by an embodiment of the present invention;
图9为本发明实施例提供的一种医疗数据的处理方法的流程图。FIG. 9 is a flowchart of a method for processing medical data provided by an embodiment of the present invention.
下面通过具体实施方式结合附图对本发明作进一步详细说明。其中不同实施方式中类似元件采用了相关联的类似的元件标号。在以下的实施方式中,很多细节描述是为了使得本申请能被更好的理解。然而,本领域技术人员可以毫不费力的认识到,其中部分特征在不同情况下是可以省略的,或者可以由其他元件、材料、方法所替代。在某些情况下,本申请相关的一些操作并没有在说明书中显示或者描述,这是为了避免本申请的核心部分被过多的描述所淹没,而对于本领域技术人员而言,详细描述这些相关操作并不是必要的,他们根据说明书中的描述以及本领域的一般技术知识即可完整了解相关操作。The present invention will be further described in detail below through specific embodiments in conjunction with the accompanying drawings. Wherein similar elements in different embodiments have used associated similar element numbers. In the following embodiments, many details are described so that the present application can be better understood. However, those skilled in the art will readily recognize that some of the features may be omitted under different circumstances, or may be replaced by other elements, materials, and methods. In some cases, some operations related to the present application are not shown or described in the specification, in order to avoid the core part of the present application from being overwhelmed by excessive description, and for those skilled in the art, these are described in detail. The relevant operations are not necessary, and they can fully understand the relevant operations according to the descriptions in the specification and general technical knowledge in the field.
另外,说明书中所描述的特点、操作或者特征可以以任意适当的方式结合形成各种实施方式。同时,方法描述中的各步骤或者动作也可以按照本领域技术人员所能显而易见的方式进行顺序调换或调整。因此,说明书和附图中的各种顺序只是为了清楚描述某一个实施例,并不意味着是必须的顺序,除非另有说明其中某个顺序是必须遵循的。Additionally, the features, acts, or characteristics described in the specification may be combined in any suitable manner to form various embodiments. At the same time, the steps or actions in the method description can also be exchanged or adjusted in order in a manner obvious to those skilled in the art. Therefore, the various sequences in the specification and drawings are only for the purpose of clearly describing a certain embodiment and are not meant to be a necessary order unless otherwise stated, a certain order must be followed.
本文中为部件所编序号本身,例如“第一”、“第二”等,仅用于区分所描述的对象,不具有任何顺序或技术含义。而本申请所说“连接”、“联接”,如无特别说明,均包括直接和间接连接(联接)。The serial numbers themselves, such as "first", "second", etc., for the components herein are only used to distinguish the described objects, and do not have any order or technical meaning. The "connection" and "connection" mentioned in this application, unless otherwise specified, include both direct and indirect connections (connections).
参见图1,示出了本发明实施例提供的一种监护设备的结构框图,该监护设备至少包括:存储器100、显示器200和处理器300;Referring to FIG. 1, it shows a structural block diagram of a monitoring device provided by an embodiment of the present invention. The monitoring device at least includes: a memory 100, a display 200, and a processor 300;
存储器100存储与对目标对象开展的治疗过程对应的预设的治疗措施集,治疗措施集包括多条治疗措施信息。需要说明的是,存储器100中所存储的治疗措施集至少包含:与对目标对象开展的治疗过程对应的治疗指南中的治疗措施信息,例如:若目标对象为脓毒症患者,存储器100中存储的治疗措施集至少包含:脓毒症指南中的治疗措施信息,以及与脓毒症相关联的其它治疗指南中的治疗措施信息。在一些具体实施例中,存储器100中所存储的治疗措施集 的治疗措施信息可来源于不同版本的治疗指南。例如,第一治疗措施集和第二治疗措施集可对应于发布于不同时间的治疗指南,第一治疗措施集和第二治疗措施集中至少部分的治疗措施信息不同。这里的不同可以包括治疗措施类型不同,也可以包括同一治疗措施的参数不同。The memory 100 stores a preset treatment measure set corresponding to the treatment process performed on the target object, and the treatment measure set includes a plurality of pieces of treatment measure information. It should be noted that the set of treatment measures stored in the memory 100 at least includes: the treatment measures information in the treatment guide corresponding to the treatment process carried out on the target object, for example: if the target object is a sepsis patient, the memory 100 stores The treatment set contains at least: treatment information in the sepsis guidelines and treatment information in other treatment guidelines related to sepsis. In some specific embodiments, the treatment action information of the treatment action set stored in the memory 100 may be derived from treatment guidelines of different versions. For example, the first treatment measure set and the second treatment measure set may correspond to treatment guidelines issued at different times, and at least part of the treatment measure information in the first treatment measure set and the second treatment measure set is different. The difference here may include different types of treatment measures, and may also include different parameters of the same treatment measure.
治疗措施集的多条治疗措施信息还可以设置有预设执行顺序,这些治疗措施信息按预设执行顺序组合起来可以形成一治疗措施序列,包含有治疗措施序列的治疗措施集又可以称为集束化治疗措施集。对应于不同版本的治疗指南时,不同治疗措施集的区别,不仅体现在前面描述的治疗措施类型或治疗参数上,还可以体现在治疗措施的预设执行顺序上。The multiple pieces of treatment measure information in the treatment measure set can also be set with a preset execution order, and the treatment measure information can be combined according to the preset execution order to form a treatment measure sequence, and the treatment measure set including the treatment measure sequence can also be called a cluster. chemotherapy treatment set. When corresponding to different versions of the treatment guideline, the difference between different treatment measure sets is not only reflected in the types of treatment measures or treatment parameters described above, but also in the preset execution order of the treatment measures.
处理器300配置用于执行下列步骤:从存储器100中获取治疗措施集,并通过显示器200显示所获取的治疗措施集的至少部分治疗措施信息;获取在治疗过程中依序产生的目标对象的治疗相关数据;根据治疗相关数据,确定治疗措施集中的治疗措施信息的执行状态,执行状态指示:治疗措施信息是否被执行以及执行时间;通过显示器200显示治疗措施信息的执行状态。The processor 300 is configured to perform the following steps: obtaining a treatment measure set from the memory 100, and displaying at least part of the treatment measure information of the obtained treatment measure set through the display 200; obtaining treatment of the target object sequentially generated during the treatment process Relevant data; according to the treatment-related data, determine the execution state of the treatment measure information in the treatment measure set, and the execution state indicates: whether the treatment measure information is executed and the execution time; the display 200 displays the execution state of the treatment measure information.
在一些具体实施例中,处理器300从存储器100中所获取的治疗措施集中的治疗措施信息,可直接来源于指定版本的治疗指南,也可来源于用户对治疗指南中的治疗措施信息进行调整形成的自定义治疗措施信息。也就是说,处理器300所获取的治疗措施集包括:指定版本的治疗指南中直接规定的治疗措施信息,和/或,用户对治疗指南中所规定的治疗措施信息进行修改后所形成的治疗措施信息。用户对治疗措施信息进行调整通常是对治疗措施信息所涉及的治疗措施的参数或顺序进行调整。In some specific embodiments, the treatment measure information in the treatment measure set obtained by the processor 300 from the memory 100 may be directly derived from a specified version of the treatment guideline, or may be derived from the user's adjustment to the treatment measure information in the treatment guideline Formed custom treatment measures information. That is to say, the treatment measure set acquired by the processor 300 includes: the treatment measure information directly specified in the treatment guideline of the specified version, and/or the treatment formed after the user modifies the treatment measure information specified in the treatment guideline Action information. The adjustment of the treatment measure information by the user is usually to adjust the parameters or sequence of the treatment measures involved in the treatment measure information.
在一些具体实施例中,操作用户可设置治疗措施集中的内容,但需要该操作用户具备相应的操作权限,处理器300配置用于:根据操作用户提交的密码信息和/或用户身份信息,对该操作用户进行身份校验,确定该操作用户是否具备治疗措施集的操作权限;若确定操作用户具备治疗措施集的操作权限,响应于操作用户的操作,设置治疗措施集的内容。In some specific embodiments, the operating user can set the content in the treatment measure set, but the operating user needs to have the corresponding operating authority, and the processor 300 is configured to: according to the password information and/or user identity information submitted by the operating user, to The operation user performs identity verification to determine whether the operation user has the operation authority of the treatment measure set; if it is determined that the operation user has the operation authority of the treatment measure set, the content of the treatment measure set is set in response to the operation of the operation user.
在一些具体实施例中,处理器300从存储器100获取治疗措施集后,控制显示器200显示至少部分的治疗措施集,也就是控制显示器200显示治疗措施集的部分治疗措施信息。如图2示出的实施例中,处理器300可控制显示器 200提供多个显示界面,其中在第一显示界面中显示治疗措施集的部分治疗措施信息。虽然图2示出多个不会同屏显示的显示界面,但在未图示的其他实施例中,处理器300可控制显示器300提供多个同屏输出的显示界面,各显示界面分别为显示器300的一个显示部分。下面的实施例中在提及第一显示界面或第二、第三显示界面时,既包括多个显示界面至少部分同屏显示的情况,也包括各个显示界面未同屏显示的情况。In some specific embodiments, after the processor 300 obtains the treatment measure set from the memory 100, the display 200 is controlled to display at least part of the treatment measure set, that is, the display 200 is controlled to display part of the treatment measure information of the treatment measure set. In the embodiment shown in FIG. 2 , the processor 300 may control the display 200 to provide a plurality of display interfaces, wherein part of the treatment measure information of the treatment measure set is displayed in the first display interface. Although FIG. 2 shows multiple display interfaces that are not displayed on the same screen, in other embodiments not shown, the processor 300 may control the display 300 to provide multiple display interfaces that output on the same screen, and each display interface is the display 300 respectively. a display part of . In the following embodiments, when referring to the first display interface or the second and third display interfaces, it includes not only a situation where multiple display interfaces are displayed on the same screen at least partially, but also a situation where each display interface is not displayed on the same screen.
在一些具体实施例中,处理器300获取在治疗过程中依序产生的目标对象的治疗相关数据,该治疗相关数据至少包括:用药事件、实际执行的治疗措施、目标对象的诊断结果和目标对象的生化检查结果中的任意一项或多项,例如:获取来自医生记录的呼吸机插管操作,来自护士的抽血操作,来自输液系统的给药数据,来自生化检验系统(如LTS系统)的生化检查指标,和来自医嘱系统的一条诊断结果等治疗相关数据。例如:获取“对于脓毒性休克的患者,选择晶体液作为初始复苏液体”这一治疗相关数据,又例如:获取“使用去甲肾上腺素联合血管加压素0.02U/min,以维持目标平均压”这一治疗相关数据。值得注意的是,治疗相关数据也可以是一条与指定版本的治疗指南中的治疗措施信息相关的唯一编码,例如:编码“SSC16-Vasoactive-01”对应脓毒症指南中血管活性药物章节的具体建议条款“推荐去甲肾上腺素作为首选升压药(强推荐、中等质量证据)”。总而言之,处理器300所获取的治疗相关数据,可来自于多个不同来源。In some specific embodiments, the processor 300 obtains treatment-related data of the target object sequentially generated during the treatment process, and the treatment-related data at least includes: medication events, actually performed treatment measures, the diagnosis results of the target object, and the target object Any one or more of the biochemical test results, such as: obtaining the ventilator intubation operation from the doctor's record, the blood drawing operation from the nurse, the drug administration data from the infusion system, from the biochemical test system (such as the LTS system) The biochemical test indicators of the patient, and the treatment-related data such as a diagnosis result from the doctor's order system. For example: obtain the treatment-related data of "for patients with septic shock, choose crystalloid as the initial resuscitation fluid", and for example: obtain "Use norepinephrine combined with vasopressin 0.02U/min to maintain the target mean pressure "This treatment-related data. It is worth noting that the treatment-related data can also be a unique code related to the treatment measures information in the specified version of the treatment guideline, for example: the code "SSC16-Vasoactive-01" corresponds to the specific details of the vasoactive drugs chapter in the sepsis guideline. The recommendation clause "recommends norepinephrine as the first-choice vasopressor (strong recommendation, moderate-quality evidence)." In summary, the treatment-related data obtained by the processor 300 may come from a number of different sources.
获取治疗相关数据时,可以先获取多种治疗相关数据,所获取的多种相关数据分别用于后续的治疗措施信息的执行状态分析。获取治疗相关数据时,也可以是先根据病症或症状选择出具体的治疗相关数据的类型,然后通过监护设备获取这些选择出类型的治疗相关数据。When obtaining the treatment-related data, various kinds of treatment-related data may be obtained first, and the obtained plurality of kinds of relevant data are respectively used for the subsequent execution state analysis of the treatment measure information. When acquiring the treatment-related data, it is also possible to first select a specific type of treatment-related data according to a disease or symptom, and then acquire these selected types of treatment-related data through a monitoring device.
在一些具体实施例中,处理器300在获取治疗相关数据后,对所有治疗相关数据进行时间同步,保证所获取的所有治疗相关数据在时间维度上的时间一致。具体实施方式可以为:处理器300获取治疗相关数据的实际产生时间,以保证所有治疗相关数据在时间维度上的时间一致。例如:假设对于抽血化验结果这一治疗相关数据,医护人员在早上10点对目标对象进行抽血,下午3点才得到抽血化验结果(抽血化验结果所指示的指标为目标对象在早上10点时 的指标),此时获取抽血化验结果的实际产生时间为早上10点而非下午3点。In some specific embodiments, after obtaining the treatment-related data, the processor 300 performs time synchronization on all the treatment-related data to ensure that all the obtained treatment-related data are consistent in time in the time dimension. The specific implementation may be as follows: the processor 300 obtains the actual generation time of the treatment-related data, so as to ensure that all the treatment-related data are consistent in time in the time dimension. For example: Suppose that for the treatment-related data of blood test results, the medical staff draws blood on the target object at 10:00 in the morning, and the blood test results are obtained at 3:00 p.m. (the index indicated by the blood test results is the target object in the morning. 10:00), the actual time for obtaining the blood test results is 10:00 a.m. instead of 3:00 p.m.
在一些具体实施例中,处理器300在获取治疗相关数据后,处理器300还配置用于提取治疗相关数据中的关键信息,该关键信息可用于与治疗措施信息进行匹配。例如:从“对于脓毒性休克的患者,选择晶体液作为初始复苏液体”之一治疗相关数据中提取“脓毒性休克”、“晶体液体”和“初始复苏液体”关键数据,又例如:从“使用去甲肾上腺素联合血管加压素0.02U/min,以维持目标平均压”这一治疗相关数据中,提取“去甲肾上腺素”、“联合”、“血管加压素”、“0.02U/min”和“目标平均压”关键信息,其中“0.02U/min”和“血管加压素”相关联。In some specific embodiments, after the processor 300 acquires the treatment-related data, the processor 300 is further configured to extract key information in the treatment-related data, where the key information can be used to match the treatment measure information. For example: extract the key data of "septic shock", "crystalloid fluid" and "initial resuscitation fluid" from one of the treatment-related data in "For patients with septic shock, choose crystalloid as the initial resuscitation fluid", another example: from " Use norepinephrine combined with vasopressin 0.02U/min to maintain the target mean blood pressure" in the treatment-related data, extract "norepinephrine", "combination", "vasopressin", "0.02U" /min" and "target mean pressure" key information, where "0.02U/min" is associated with "vasopressin".
在一些具体实施例中,处理器300在获取治疗相关数据之后,根据该治疗相关数据,确定处理器300所获取的治疗措施集中的治疗措施信息的执行状态,该执行状态可用于指示治疗措施信息是否被执行以及执行治疗措施信息的执行时间。在具体实现中,针对每条治疗相关数据,处理器300利用该治疗相关数据对治疗措施集中的治疗措施信息进行匹配,确定该治疗相关数据是否与一条或多条治疗措施信息相匹配,根据是否匹配的结果对该治疗相关数据进行标记,以表示该治疗相关数据与哪些治疗措施信息匹配。同样地,在一些其他实施例中,处理器300也可以判断治疗相关数据是否与部分或任一治疗措施信息不匹配,根据判断结果对该治疗相关数据进行标记,以表示该治疗相关数据与哪些治疗措施信息相匹配。例如,可以给治疗相关数据提供表示“符合”或“不符合”的标记。该治疗相关的标记可以理解为治疗措施信息与治疗相关数据之间的匹配信息。通过治疗相关数据的匹配信息,可确定治疗措施集中的哪些治疗措施信息已被执行,再基于该治疗相关数据的执行时间,得到相应治疗措施信息的执行状态。例如:利用从“使用去甲肾上腺素联合血管加压素0.02U/min,以维持目标平均压”这一治疗相关数据中所提取的关键信息,与脓毒症指南中血管活性药物章节的条款“2.为达到目标平均动脉压(MAP),建议使用去甲肾上腺素联合血管加压素(最大剂量0.03U/min)(弱推荐、中等质量证据)或肾上腺素(弱推荐、低质量证据),或加用血管加压素(最大剂量0.03U/min)(弱推荐、中等质量证据)以降低去甲肾上腺素剂量”相匹配,则在该治疗相关数据中标记“符合SSC16-Vasoactive-02”,此时也指示该条款对应的治疗措 施信息已被执行。处理器300控制显示器200显示治疗措施信息的执行状态,如图2示出的第一显示界面的示意图中,该第一显示界面中显示了多条治疗措施信息(如图2中的治疗措施信息1至4),可通过在治疗措施信息左方的矩形框中标记“√”来表示治疗措施信息被执行(如治疗措施信息1被执行),以及在治疗措施信息右方显示治疗措施信息的执行时间。需要说明的是,图2中所示出的内容仅用于举例说明,也可以通过其它方式来表示治疗措施信息被执行(如已被执行的治疗措施信息加粗加黑,或者,已被执行的治疗措施信息左侧的矩形框填充黑色),以及也可通过其它方式表示治疗措施信息的执行时间。In some specific embodiments, after obtaining the treatment-related data, the processor 300 determines, according to the treatment-related data, the execution state of the treatment measure information in the treatment measure set obtained by the processor 300, where the execution state may be used to indicate the treatment measure information Whether it was performed and when the treatment was performed information. In a specific implementation, for each piece of treatment-related data, the processor 300 uses the treatment-related data to match the treatment-measure information in the treatment-measure set, and determines whether the treatment-related data matches one or more pieces of treatment-measure information. The matching result marks the treatment-related data to indicate to which treatment measure information the treatment-related data matches. Similarly, in some other embodiments, the processor 300 can also judge whether the treatment-related data does not match some or any of the treatment measures information, and mark the treatment-related data according to the judgment result to indicate which treatment-related data is associated with information on treatment measures. For example, treatment-related data may be provided with a flag indicating "meet" or "non-compliance." The treatment-related markers can be understood as matching information between treatment measure information and treatment-related data. Through the matching information of the treatment-related data, it can be determined which treatment measure information in the treatment measure set has been executed, and then based on the execution time of the treatment-related data, the execution status of the corresponding treatment measure information can be obtained. Example: Using key information extracted from the treatment-related data "Use of norepinephrine in combination with vasopressin 0.02 U/min to maintain target mean blood pressure" in conjunction with the provisions of the vasoactive drugs chapter of the sepsis guidelines "2. To achieve target mean arterial pressure (MAP), it is recommended to use norepinephrine combined with vasopressin (maximum dose 0.03 U/min) (weak recommendation, moderate-quality evidence) or epinephrine (weak recommendation, low-quality evidence) ), or the addition of vasopressin (maximum dose 0.03 U/min) (weak recommendation, moderate-quality evidence) to reduce the dose of norepinephrine", then the treatment-related data were marked "compliant with SSC16-Vasoactive- 02", at this time, it also indicates that the treatment measure information corresponding to this clause has been implemented. The processor 300 controls the display 200 to display the execution state of the treatment measure information. In the schematic diagram of the first display interface shown in FIG. 2 , the first display interface displays a plurality of pieces of treatment measure information (the treatment measure information in FIG. 2 ). 1 to 4), you can mark "√" in the rectangular box to the left of the treatment information to indicate that the treatment information is executed (such as treatment information 1 is executed), and display the treatment information on the right of the treatment information. execution time. It should be noted that the content shown in FIG. 2 is only for illustration, and other methods may also be used to indicate that the treatment measure information is executed (for example, the treatment measure information that has been executed is bold and black, or, the treatment measure information that has been executed has been executed. The rectangle box to the left of the treatment measure information is filled with black), and the execution time of the treatment measure information may also be represented in other ways.
治疗措施集所包括的多条治疗措施信息还可以设置有执行顺序,这些按照预设执行顺序执行的治疗措施信息可形成一治疗措施序列。在一些具体实施例中,对于包含治疗措施序列的治疗措施集,处理器300可进一步但非必需配置用于确定治疗措施集中已执行的治疗措施的执行顺序是否符合预设执行顺序。即,处理器300不仅用于确定治疗相关数据与治疗措施集中的治疗措施信息是否匹配,而且在识别到与治疗措施信息匹配的治疗相关数据后,进一步判断各条治疗相关数据的产生时间(即与之对应的治疗措施信息的执行时间)的先后顺序,是否与相应治疗措施信息的预设执行顺序相匹配。在具体实现中,针对每条治疗相关数据,处理器300利用该治疗相关数据对治疗措施集中的治疗措施信息进行匹配,不仅确定该治疗相关数据是否与一条或多条治疗措施信息相匹配,而且确定该治疗相关数据对应的时间是否与治疗措施信息的预设执行顺序相匹配,根据是否匹配的结果对该治疗相关数据进行标记,以表示该治疗相关数据与治疗措施信息及其执行顺序的匹配结果。例如,可以给治疗相关数据提供表示“符合内容且符合顺序”、“符合内容但不符合顺序”或“不符合”的标记。这里的不符合指治疗措施集里并未发现与治疗相关数据匹配的治疗措施信息,相应也就无需再进行执行顺序的分析判断。该治疗相关的标记可以理解为治疗措施信息与治疗相关数据之间的匹配信息。通过治疗相关数据的匹配信息,可确定治疗措施集中的哪些治疗措施信息已被执行以及是否按预设执行顺序执行,再基于该治疗相关数据的执行时间,得到相应治疗措施信息的执行状态。The multiple pieces of treatment measure information included in the treatment measure set may also be set with an execution sequence, and the treatment action information executed according to the preset execution sequence may form a treatment action sequence. In some specific embodiments, for a treatment measure set including a sequence of treatment measures, the processor 300 may be further, but not necessarily, configured to determine whether the execution order of the executed treatment measures in the treatment measure set conforms to a preset execution order. That is, the processor 300 is not only used to determine whether the treatment-related data matches the treatment-measure information in the treatment-measure set, but also, after identifying the treatment-related data matching the treatment-measure information, further determine the generation time of each piece of treatment-related data (ie, Whether the order of execution time of the corresponding treatment measure information) matches the preset execution order of the corresponding treatment measure information. In a specific implementation, for each piece of treatment-related data, the processor 300 uses the treatment-related data to match the treatment measure information in the treatment measure set, not only to determine whether the treatment-related data matches one or more pieces of treatment measure information, but also Determine whether the time corresponding to the treatment-related data matches the preset execution order of the treatment measure information, and mark the treatment-related data according to the result of matching to indicate the matching of the treatment-related data with the treatment measure information and its execution order result. For example, treatment-related data may be provided with tags indicating "content and sequence," "content but not sequence," or "not conforming." The non-conformity here means that no treatment measure information matching the treatment-related data is found in the treatment measure set, and accordingly, there is no need to analyze and judge the execution order. The treatment-related markers can be understood as matching information between treatment measure information and treatment-related data. Through the matching information of the treatment-related data, it is possible to determine which treatment-measure information in the treatment-measure set has been executed and whether it is executed in a preset execution order, and then obtain the execution status of the corresponding treatment-measure information based on the execution time of the treatment-related data.
在一些具体实施例中,处理器300可从治疗相关数据中提取关键信息,然后基于提取的关键信息与治疗措施集中的治疗措施信息进行是否相匹配的分析判断;处理器300也可以先基于治疗措施集的治疗措施信息进行训练,从而在获取到治疗相关数据中,基于机器学习来直接识别属于治疗措施信息的治疗相关数据,据此确定治疗措施信息的执行状态。处理器300根据治疗相关数据得到治疗措施信息的执行状态可不受限于上述两种实施方式,其他等同实施方式同样在本申请所希望保护的范围内。In some specific embodiments, the processor 300 may extract key information from the treatment-related data, and then analyze and determine whether the extracted key information matches the treatment measure information in the treatment measure set; The treatment-measure information of the measure set is trained, so that in the obtained treatment-related data, the treatment-related data belonging to the treatment-measure information is directly identified based on machine learning, and the execution state of the treatment-measure information is determined accordingly. The execution state in which the processor 300 obtains the treatment measure information according to the treatment-related data may not be limited to the above two embodiments, and other equivalent embodiments are also within the scope of the intended protection of the present application.
在一些具体实施例中,处理器300所获取的治疗措施集至少包括与特定病症关联的集束化治疗措施集,例如与脓毒症关联的集束化治疗措施集。与脓毒症关联的集束化治疗措施集包括一系列需由有序执行的治疗措施信息,也即包括治疗措施序列。处理器300还配置用于:通过显示器200显示至少部分的集束化治疗措施集;根据治疗相关数据标记集束化治疗措施集中已被执行的治疗措施信息,并显示已被执行的治疗措施集的执行时间。如图3示出的第一显示界面的示例图,需要说明的是,图3中的“集束化治疗”界面即为第一显示界面,“支持治疗”界面为以下内容中提及的第三显示界面,“过程跟踪”界面为以下内容中提及的“第二显示界面”。处理器300在第一显示界面中显示一组需在3小时内完成的集束化治疗措施集;如图3,当通过治疗相关数据确定“监测血乳酸水平”和“应用抗生素前获取血培养标本”这两条治疗措施信息被执行,则在被执行的治疗措施信息左侧方框标记“√”以表示治疗措施信息被执行,以及在被执行的治疗措施信息右侧显示治疗措施信息的执行时间。需要说明的是,操作用户可以手动输入某一治疗措施信息的执行状态,如图3中,操作用户可手动在某一治疗措施信息左侧的方框内标记“√”,此时可由用户手动输入或自动获取治疗措施信息的执行时间并对其进行显示。在未图示的实施例中,在图3所示出的执行状态基础上,处理器可进一步确定所标记“√”的治疗措施信息是否依序执行。In some specific embodiments, the set of treatment measures obtained by the processor 300 includes at least a set of bundled treatment measures associated with a specific condition, such as a set of bundled treatment measures associated with sepsis. A bundle of treatment measures associated with sepsis includes information on a series of treatment measures to be executed in an orderly manner, that is, a sequence of treatment measures. The processor 300 is further configured to: display at least a part of the bundle treatment measure set through the display 200; mark the information of the treatment measures that have been performed in the bundle therapy measure set according to the treatment-related data, and display the execution of the performed treatment measure set time. Fig. 3 is an example diagram of the first display interface. It should be noted that the "bundle therapy" interface in Fig. 3 is the first display interface, and the "supportive therapy" interface is the third interface mentioned in the following content. Display interface, the "process tracking" interface is the "second display interface" mentioned in the following content. The processor 300 displays a set of bundled treatment measures that need to be completed within 3 hours in the first display interface; as shown in Figure 3, when "monitoring blood lactate level" and "obtaining blood culture specimens before antibiotics are determined" through treatment-related data ” If these two pieces of treatment measure information are executed, the box on the left side of the executed treatment measure information will mark “√” to indicate that the treatment measure information is executed, and the execution of the treatment measure information will be displayed on the right side of the executed treatment measure information. time. It should be noted that the operating user can manually input the execution status of a certain treatment measure information. As shown in Figure 3, the operating user can manually mark "√" in the box on the left side of a certain treatment measure information. At this time, the user can manually Enter or automatically obtain the execution time of treatment information and display it. In the embodiment not shown, on the basis of the execution state shown in FIG. 3 , the processor may further determine whether the information of the treatment measures marked with “√” is executed in sequence.
可以理解的是,所显示的集束化治疗措施集中的治疗措施信息,可来自于不同时间版本的集束化治疗措施集,即操作用户可从不同时间版本的集束化治疗措施集中选择需显示的治疗措施信息。在一些具体实施例中,集束化治疗措施集包括不同时间版本的第一集束化治疗措施集和第二集束化治疗措施集,第 一集束化治疗措施集和第二集束化治疗措施集具有至少部分不同的治疗措施信息。处理器300还配置用于:接收操作用户对第一集束化治疗措施集和第二集束化治疗措施集的选择,并在显示器200上显示操作用户选定的选择结果。It can be understood that the displayed treatment information in the bundled treatment set can come from different time versions of the bundled treatment set, that is, the operating user can select the treatment to be displayed from the bundled treatment set of different time versions. Action information. In some specific embodiments, the bundled therapy measure set includes a first bundled therapy measure set and a second bundled therapy measure set of different time versions, and the first bundled therapy measure set and the second bundled therapy measure set have at least Some of the different treatments available. The processor 300 is further configured to: receive the selection of the first bundle treatment measure set and the second bundle treatment measure set by the operating user, and display the selection result selected by the operating user on the display 200 .
可以理解的是,在治疗措施集中,还预置了一系列的结构化治疗建议和治疗参考等信息,该结构化治疗建议和治疗参考等信息主要是通过大量临床数据和经验所得到的,因此结构化治疗建议和治疗参考等信息也可作为治疗措施集中的治疗措施信息。在一些具体实施例中,治疗措施集还包括与特定病症关联的辅助治疗措施集,例如与脓毒症关联的辅助治疗措施集。辅助治疗措施集可以包含治疗措施序列,也可以仅包含无预设执行顺序的多条治疗措施信息。处理器300还配置用于:通过显示器200显示至少部分的辅助治疗措施集,并根据治疗相关数据,标识已被执行的治疗措施信息的执行状态和执行时间。如图4示出的示意图,其中辅助治疗措施集包括的治疗措施信息无预设执行顺序,在第三显示界面中至少显示辅助治疗措施集中的部分治疗措施信息(治疗措施信息1至4),第三显示界面中关于如何标识已被执行的治疗措施信息的执行状态和执行时间,可参见上述图2示出的内容,在此不再赘述。在一些实施例中,当特定病症为脓毒症时,辅助治疗措施集中的治疗措施信息可以是治疗建议,如图5示出的第三显示界面的示例图,图5中的“支持治疗”界面为第三显示界面,在“支持治疗”界面中显示血管活性药物部分的若干条治疗建议(也就是辅助治疗措施集中的治疗措施信息),若干条治疗建议的内容详见图5,其中,图5中关于如何标识已被执行的治疗措施信息的执行状态和执行时间,可参见上述图3示出的内容,在此不再赘述。It is understandable that, in the treatment measures set, a series of information such as structured treatment recommendations and treatment references are also preset. The structured treatment recommendations and treatment references are mainly obtained through a large amount of clinical data and experience. Therefore, Information such as structured treatment recommendations and treatment references are also available as treatment action information in treatment action sets. In some embodiments, the set of therapeutic measures also includes a set of adjuvant therapy measures associated with a particular condition, such as a set of adjuvant therapy measures associated with sepsis. The adjuvant therapy measure set may contain a sequence of therapy measures, or may only contain multiple pieces of therapy measure information without a preset execution sequence. The processor 300 is further configured to: display at least a part of the auxiliary treatment measure set through the display 200, and identify the execution status and execution time of the executed treatment measure information according to the treatment-related data. As shown in the schematic diagram shown in FIG. 4 , the treatment measure information included in the auxiliary treatment measure set has no preset execution order, and at least part of the treatment measure information (treatment measure information 1 to 4) in the auxiliary treatment measure set is displayed in the third display interface, Regarding how to identify the execution state and execution time of the treatment measure information that has been executed in the third display interface, reference may be made to the content shown in FIG. 2 above, which will not be repeated here. In some embodiments, when the specific condition is sepsis, the treatment measure information in the adjuvant treatment measures set may be treatment suggestions, as shown in the example diagram of the third display interface shown in FIG. 5 , the “supportive care” in FIG. 5 The interface is the third display interface. In the "supportive care" interface, several treatment suggestions (that is, the treatment measures information in the adjuvant treatment measures) are displayed in the vasoactive drug section. The contents of the several treatment suggestions are shown in Figure 5. Among them, Regarding how to identify the execution status and execution time of the executed treatment measure information in FIG. 5 , reference may be made to the content shown in FIG. 3 above, which will not be repeated here.
在一些具体实施例中,处理器300还配置用于:确定每一治疗相关数据与治疗措施集中的治疗措施信息之间的匹配信息,并将匹配信息存储至存储器100中,匹配信息指示:治疗相关数据与治疗措施集中的至少一条治疗措施信息相匹配,或治疗相关数据与治疗措施集中的任一条治疗措施信息不匹配。通过某一治疗相关数据的匹配信息,可直观了解到该治疗相关数据所对应的治疗过程是否符合与该治疗相关数据对应的治疗措施信息,也就是说,通过匹配信息,可直观了解到治疗过程是否遵循治疗措施集中的治疗措施信息;当某一治疗相关数据所对应的治疗过程不符合对应的治疗措施信息时,可通过匹配信息 直观了解到治疗相关数据与治疗措施信息之间存在差异。In some specific embodiments, the processor 300 is further configured to: determine matching information between each treatment-related data and the treatment measure information in the treatment measure set, and store the matching information in the memory 100, the matching information indicating: the treatment The relevant data matches at least one piece of treatment measure information in the treatment measure set, or the treatment-related data does not match any piece of treatment measure information in the treatment measure set. Through the matching information of a certain treatment-related data, it is possible to intuitively know whether the treatment process corresponding to the treatment-related data conforms to the treatment measure information corresponding to the treatment-related data. That is to say, through the matching information, one can intuitively understand the treatment process. Whether to follow the treatment measure information in the treatment measure set; when the treatment process corresponding to a certain treatment-related data does not conform to the corresponding treatment measure information, you can intuitively understand the difference between the treatment-related data and the treatment measure information through the matching information.
在一些具体实施例中,处理器300还配置用于:通过显示器200,按照治疗相关数据产生的时间先后顺序,显示治疗相关数据、或者显示治疗相关数据以及治疗相关数据对应的匹配信息。如图6示出的第二显示界面的示意图,第二显示界面中包含第一显示区域和第二显示区域,在一些实施例中,在第二显示界面的第二显示区域中显示治疗相关数据,或者显示治疗相关数据以及治疗相关数据对应的匹配信息。In some specific embodiments, the processor 300 is further configured to: display the treatment-related data, or display the treatment-related data and the matching information corresponding to the treatment-related data, through the display 200 according to the chronological order in which the treatment-related data is generated. FIG. 6 is a schematic diagram of the second display interface. The second display interface includes a first display area and a second display area. In some embodiments, treatment-related data is displayed in the second display area of the second display interface. , or display treatment-related data and matching information corresponding to the treatment-related data.
在一些具体实施例中,处理器300配置用于:获取在治疗过程中依序产生的目标对象的生理体征数据,例如获取来自于监护设备的目标对象的生理体征数据(心率值、血氧饱和度与Hb等生理体征数据);生成生理体征数据对应的显示信息,显示信息至少包括波形显示信息;通过显示器200的第一显示区域显示生理体征数据对应的显示信息;在第二显示区域显示治疗相关数据、或者显示治疗相关数据和治疗相关数据对应的匹配信息。如图6示出的第二显示界面的示意图,该第二显示界面包括第一显示区域和第二显示区域,在第一显示区域显示该目标对象的生理体征数据对应的显示信息;在第二显示区域显示治疗相关数据、或者显示治疗相关数据和治疗相关数据对应的匹配信息。通过第二显示界面,可直观了解目标对象的生理体征数据的变化,以及直观了解治疗过程中所产生的治疗相关数据及其匹配信息。In some specific embodiments, the processor 300 is configured to: obtain the physiological sign data of the target object generated in sequence during the treatment process, for example, obtain the physiological sign data (heart rate value, blood oxygen saturation) of the target object from the monitoring device Physiological sign data such as degree and Hb); generate display information corresponding to the physiological sign data, and the display information includes at least waveform display information; display the display information corresponding to the physiological sign data through the first display area of the display 200; display the treatment in the second display area related data, or display treatment-related data and matching information corresponding to the treatment-related data. 6 is a schematic diagram of the second display interface, the second display interface includes a first display area and a second display area, and the display information corresponding to the physiological sign data of the target object is displayed in the first display area; in the second display area The display area displays the treatment-related data, or displays the treatment-related data and matching information corresponding to the treatment-related data. Through the second display interface, it is possible to intuitively understand the changes of the physiological sign data of the target object, as well as the treatment-related data and its matching information generated during the treatment process.
可以理解的是,由上述内容可知,处理器300所获取的治疗相关数据为在治疗过程中依序产生的,以及所获取的生理体征数据也是依序产生的,因此,可通过在第二显示界面设置一时间轴,展示不同时间的生理体征数据和治疗相关数据。It can be understood that, from the above content, the treatment-related data acquired by the processor 300 are sequentially generated during the treatment process, and the acquired physiological sign data are also sequentially generated. A time axis is set on the interface to display physiological sign data and treatment-related data at different times.
在一些具体实施例中,第一显示区域包括时间轴和可移动的游标,在第一显示区域显示时间轴中由游标指向的时间对应的生理体征数据的体征值和治疗相关数据的概况信息,以及在第二显示区域突出显示时间轴中由游标指向的时间对应的治疗相关数据、或者突出显示治疗相关数据及治疗相关数据对应的匹配信息。In some specific embodiments, the first display area includes a time axis and a movable cursor, and the first display area displays the sign value of the physiological sign data and the overview information of the treatment-related data corresponding to the time pointed by the cursor in the time axis, And, in the second display area, the treatment-related data corresponding to the time pointed by the cursor in the time axis is highlighted, or the treatment-related data and the matching information corresponding to the treatment-related data are highlighted.
可以理解的是,为使操作用户在第二显示界面更快速的定位到某一治疗相关数据,可在第一显示区域所显示的时间轴中设置治疗事件图标,治疗事件图 标指示该治疗事件图标所在时间轴中的时间存在治疗相关数据。在一些具体实施例中,在第一显示区域的时间轴上显示用于指示存在治疗相关数据的治疗事件图标,并在时间轴上显示游标指向的治疗事件图标所对应的治疗相关数据的概况信息,以及在第二显示区域突出显示游标指向的治疗事件图标所对应的治疗相关数据、或者突出显示治疗相关数据和治疗相关数据对应的匹配信息。It can be understood that, in order to enable the operating user to more quickly locate a certain treatment-related data on the second display interface, a treatment event icon can be set in the time axis displayed in the first display area, and the treatment event icon indicates the treatment event icon. Treatment-related data exists at the time in the timeline. In some specific embodiments, a treatment event icon for indicating the existence of treatment-related data is displayed on the time axis of the first display area, and overview information of the treatment-related data corresponding to the treatment event icon pointed to by the cursor is displayed on the time axis , and the treatment-related data corresponding to the treatment event icon pointed to by the cursor, or the matching information corresponding to the treatment-related data and the treatment-related data are highlighted in the second display area.
例如:如图7示出的第二显示界面的示例图,在第二显示界面的第一显示区域显示目标对象的生理体征数据的波形显示信息,以及在第二显示区域显示目标对象的治疗相关数据。在图7中,“过程跟踪”界面即为第二显示界面,501为上述提及的可以移动的游标,502为游标指向的时间对应的生理体征数据的体征值,503为用药事件(展示一段时间内的用药概况),当该游标所指向的时间存在用药事件则显示用药详情,504为上述提及的治疗事件图标(可通过填充黑色的三角形或者其它表现形式来表示治疗事件图标),505为治疗事件图标所对应的治疗相关数据(例如实际执行的治疗措施及执行时间)。如图7,当游标移动至“去甲肾上腺素0.2mg,加压素0.03U/min”这一治疗事件图标时,在第一显示区域的时间轴上突出显示该治疗事件图标所对应的治疗相关数据的概况信息“去甲肾上腺素0.2mg,加压素0.03U/min”,在第一显示区域的右侧显示游标指向的时间对应的生理体征数据的体征值“CPV(中心静脉压)12、MAP(平均动脉压)68(120/78)和ScvO2(中心性静脉血氧饱和度)87”;在第二显示区域中突出显示该治疗事件图标对应的治疗相关数据“2020-3-1510:02推荐在建立新的血管通路后,立即拔出可能引起脓毒症或脓毒性休克的血管内通路装置(BPS)”。For example, as shown in the example diagram of the second display interface in FIG. 7 , the waveform display information of the physiological sign data of the target object is displayed in the first display area of the second display interface, and the treatment-related information of the target object is displayed in the second display area. data. In Fig. 7, the "process tracking" interface is the second display interface, 501 is the above-mentioned movable cursor, 502 is the physical sign data corresponding to the time pointed by the cursor, and 503 is the medication event (showing a section of Medication overview in time), when there is a medication event at the time pointed by the cursor, the medication details will be displayed, 504 is the above-mentioned treatment event icon (the treatment event icon can be represented by a filled black triangle or other forms), 505 It is the treatment-related data corresponding to the treatment event icon (such as the actual treatment measures and execution time). As shown in Figure 7, when the cursor moves to the treatment event icon "norepinephrine 0.2 mg, vasopressin 0.03 U/min", the treatment corresponding to the treatment event icon will be highlighted on the time axis of the first display area The general information of the relevant data is "norepinephrine 0.2mg, vasopressin 0.03U/min", on the right side of the first display area, the sign value of the physiological sign data corresponding to the time pointed by the cursor is displayed "CPV (central venous pressure)" 12. MAP (mean arterial pressure) 68 (120/78) and ScvO2 (central venous oxygen saturation) 87"; in the second display area, highlight the treatment-related data corresponding to the treatment event icon "2020-3- 1510:02 recommends immediate removal of endovascular access devices (BPS) that may cause sepsis or septic shock after establishing new vascular access.”
需要说明的是,图7所示出的第二显示界面中第一显示区域和第二显示区域的位置以及体征值的显示位置,仅用于举例说明,在实际应用中可根据实际情况对第一显示区域和第二显示区域的位置以及体征值的显示位置进行设置,在此不做具体限定。It should be noted that the positions of the first display area and the second display area and the display positions of the vital values in the second display interface shown in FIG. 7 are only used for illustration. The positions of the first display area and the second display area and the display positions of the vital values are set, which are not specifically limited here.
可以理解的是,上述图7所示出的示例图中,第二显示区域只显示治疗事件图标对应的治疗相关数据;关于第二显示区域显示治疗事件图标对应的治疗相关数据及治疗相关数据对应的匹配信息的示例,参见以下图8示出的示例图。It can be understood that, in the example diagram shown in FIG. 7 above, the second display area only displays the treatment-related data corresponding to the treatment event icon; about the second display area, the treatment-related data corresponding to the treatment event icon and the treatment-related data corresponding to the treatment event icon are displayed. For an example of matching information of , see the example diagram shown in Figure 8 below.
如图8示出的第二显示界面的另一示例图,在第二显示界面的第一显示区域显示目标对象的生理体征数据的波形显示信息,以及在第二显示区域显示目标对象的治疗相关数据及治疗相关数据对应的匹配信息。在图8中,“过程跟踪”界面即为第二显示界面,501为上述提及的可以移动的游标,505-1为治疗事件图标所对应的治疗相关数据(如所执行的治疗措施)以及治疗相关数据对应的匹配信息,该匹配信息可用于指示治疗相关数据是否符合治疗措施集中的治疗措施信息,通过符号“√”来表示符合治疗措施集中的治疗措施信息,通过符号“×”来表示不符合治疗措施集中的治疗措施信息(与此同时,显示与哪一治疗措施信息不符合或者说存在差异,并以诸如加黑和/或加粗的方式标记出差异内容)。如图8,当游标移动至“去甲肾上腺素0.2mg,加压素0.03U/min”这一治疗事件图标时,在第一显示区域的时间轴上突出显示该治疗事件图标所对应的治疗相关数据的概况信息“去甲肾上腺素0.2mg,加压素0.03U/min”;在第二显示区域中突出显示该治疗事件图标对应的治疗相关数据“2020-3-1507:53血压为80/65(48)时,按20ml/kg给予晶体液”,该治疗相关数据被标记“×”表示不符合“4.对脓毒症导致组织灌注不足且怀疑有血容量不足的患者,早期液体冲击疗法应至少按30mL/kg的剂量输注晶体液……”这一治疗措施集中的治疗措施信息,此时加黑“30mL/kg”这一内容来标记出与该治疗措施信息之间的差异内容。需要说明的是,图8中第二显示区域所显示的治疗相关数据可以是临床日常用语。As another example of the second display interface shown in FIG. 8 , the waveform display information of the physiological sign data of the target object is displayed in the first display area of the second display interface, and the treatment-related information of the target object is displayed in the second display area. Matching information corresponding to data and treatment-related data. In Fig. 8, the "process tracking" interface is the second display interface, 501 is the above-mentioned movable cursor, 505-1 is the treatment-related data (such as the executed treatment measures) corresponding to the treatment event icon, and Matching information corresponding to the treatment-related data, which can be used to indicate whether the treatment-related data conforms to the treatment measure information in the treatment measure set. The symbol “√” indicates that it conforms to the treatment measure information in the treatment measure set, and the symbol “×” indicates Not conforming to the treatment measure information in the treatment measure set (at the same time, showing which treatment measure information is inconsistent with or having a difference, and marking the difference content in a manner such as blackening and/or bolding). As shown in Figure 8, when the cursor moves to the treatment event icon "norepinephrine 0.2 mg, vasopressin 0.03 U/min", the treatment corresponding to the treatment event icon will be highlighted on the time axis of the first display area The overview information of the relevant data "norepinephrine 0.2mg, vasopressin 0.03U/min"; in the second display area, highlight the treatment-related data corresponding to the treatment event icon "2020-3-1507:53 blood pressure is 80 When /65 (48), give crystalloid solution at 20ml/kg", the treatment-related data are marked with "x" to indicate that it does not meet "4. For patients with tissue hypoperfusion caused by sepsis and suspected hypovolemia, early fluid Pulse therapy should be infused with crystalloids at a dose of at least 30mL/kg..." This treatment measures information on the treatment measures, at this time, the content of "30mL/kg" is blackened to mark the difference with the treatment measures information. Difference content. It should be noted that, the treatment-related data displayed in the second display area in FIG. 8 may be clinical daily words.
在未图示的实施例中,可以在图8的显示基础上,进一步在区域505-1中显示治疗相关数据对应的治疗措施信息是否按照预设执行顺序执行的匹配信息。例如,可在区域505-1的治疗相关数据后直接标明是否符合预设执行顺序。例如,符合预设执行顺序时显示“符合执行顺序”,与预设执行顺序出现偏差时显示“执行顺序有误”,并可选地提供对应治疗相关数据相对于其他治疗相关数据应该出现的顺序,或者提供治疗相关数据对应的治疗措施信息应该执行的顺序,从而辅助用户更快了解到当前对目标对象的治疗在哪一环节出错。In the embodiment not shown, on the basis of the display in FIG. 8 , matching information of whether the treatment measure information corresponding to the treatment-related data is executed according to the preset execution order may be further displayed in the area 505 - 1 . For example, whether the treatment-related data in the area 505-1 conforms to the preset execution order may be directly marked. For example, if it conforms to the preset execution order, it will display "in accordance with the execution order", and if it deviates from the preset execution order, it will display "execution order is wrong", and optionally provide the order in which the corresponding treatment-related data should appear relative to other treatment-related data. , or provide the order in which the treatment measures information corresponding to the treatment-related data should be executed, so as to assist the user to quickly understand which link in the current treatment of the target object is wrong.
在一些实施例中,处理器300可在预设时间段内统计治疗措施集中治疗措施信息的执行情况,可以将该执行情况直接提示给用户,也可以向用户提示必需依序执行的治疗措施集中经常被忽视的治疗措施信息或经常执行顺序出错 的治疗措施信息,或者也可以向用户提示一些代表处置建议的治疗措施集中使用频率最高的治疗措施信息。这些对治疗相关数据的分析,均可以提高监护设备的使用智能性。In some embodiments, the processor 300 may collect statistics on the execution of the treatment measure information in the treatment measure set within a preset time period, and may directly prompt the user about the execution status, or may prompt the user of the treatment measure set that must be executed in sequence. Information about treatment measures that are often overlooked or information about treatment measures that are often executed in an incorrect order, or can also prompt the user for information about treatment measures that are most frequently used in a concentrated set of treatment measures that represent treatment recommendations. These analysis of treatment-related data can improve the intelligence of the use of monitoring equipment.
需要说明的是,上述图2至图8所示出的第一显示界面、第二显示界面和第三显示界面的排序顺序仅用于示例,也可根据实际情况进行调整。It should be noted that the sorting order of the first display interface, the second display interface and the third display interface shown in FIG. 2 to FIG. 8 is only for example, and can also be adjusted according to actual conditions.
通过以上内容,针对某种疾病或者症状,能快速、完整和准确的记录所采取的相关治疗和护理措施行为,用户可自定义所参考的指南版本,提高用户对以脓毒症为代表的病症进行有序跟踪管理的灵活性。Through the above content, for a certain disease or symptom, the relevant treatment and nursing measures can be quickly, completely and accurately recorded. Users can customize the version of the guide they refer to, so as to improve users' understanding of diseases represented by sepsis. Flexibility for orderly tracking management.
以上内容是关于监护设备的一些说明。本发明一些实施例中还公开了医疗数据的处理方法。These are some notes about monitoring equipment. A method for processing medical data is also disclosed in some embodiments of the present invention.
参见图9,示出了本发明实施例提供的一种医疗数据的处理方法的流程图,该处理方法包括:Referring to FIG. 9 , a flowchart of a medical data processing method provided by an embodiment of the present invention is shown, and the processing method includes:
步骤S901:获取与对目标对象开展的治疗过程对应的预设的治疗措施集。需要说明的是,治疗措施集包括多条治疗措施信息。Step S901: Acquire a preset treatment measure set corresponding to the treatment process performed on the target object. It should be noted that the treatment measure set includes multiple pieces of treatment measure information.
在一些具体实施例中,治疗措施集包括:指定版本的治疗指南中的治疗措施信息,和/或,操作用户对治疗指南中的治疗措施信息调整后形成的用户自定义治疗措施信息。In some specific embodiments, the treatment measure set includes: treatment measure information in a prescribed version of the treatment guideline, and/or user-defined treatment measure information formed after the manipulation user adjusts the treatment measure information in the treatment guideline.
在一些具体实施例中,操作用户在设置治疗措施集的内容之前,根据操作用户提交的密码信息和/或用户身份信息,确定操作用户是否具备治疗措施集的操作权限;若操作用户具备治疗措施集的操作权限,响应于操作用户的操作,设置治疗措施集的内容。In some specific embodiments, before setting the content of the therapeutic measure set, the operating user determines whether the operating user has the operating authority of the therapeutic measure set according to the password information and/or user identity information submitted by the operating user; if the operating user has the therapeutic measure The operation authority of the set, in response to the operation of the operation user, sets the content of the treatment measure set.
步骤S902:获取在治疗过程中依序产生的目标对象的治疗相关数据。Step S902: Acquire the treatment-related data of the target object sequentially generated in the treatment process.
在一些具体实施例中,治疗相关数据至少包括以下的至少之一:用药事件、实际执行的治疗措施、目标对象的诊断结果和目标对象的生化检查结果。In some specific embodiments, the treatment-related data includes at least one of the following: medication events, actually performed treatment measures, diagnostic results of the target subject, and biochemical examination results of the target subject.
步骤S903:确定每一治疗相关数据与治疗措施集中的治疗措施信息之间的匹配信息。Step S903: Determine matching information between each treatment-related data and the treatment measure information in the treatment measure set.
需要说明的是,匹配信息指示:治疗相关数据与治疗措施集中的至少一条治疗措施信息相匹配或不匹配。在一些具体实施例中,确定每一治疗相关数据与治疗措施集中的治疗措施信息之间的匹配信息之前,获取治疗相关数据的实 际产生时间。在一些具体实施例中,确定每一治疗相关数据与治疗措施集中的治疗措施信息之间的匹配信息之前,提取治疗相关数据中的关键信息。It should be noted that the matching information indicates that the treatment-related data matches or does not match at least one piece of treatment measure information in the treatment measure set. In some embodiments, the actual generation time of the treatment-related data is obtained before determining the match information between each treatment-related data and the treatment measure information in the treatment measure set. In some embodiments, key information in the treatment-related data is extracted prior to determining matching information between each treatment-related data and treatment-measure information in the treatment-measure set.
步骤S904:根据治疗相关数据与治疗措施信息的匹配信息,确定治疗措施集中治疗措施信息的执行状态。Step S904: According to the matching information between the treatment-related data and the treatment measure information, determine the execution state of the treatment measure information in the treatment measure set.
需要说明的是,执行状态指示:治疗措施信息是否被执行以及执行时间。一些实施例中,执行状态还可以进一步包括治疗措施信息的执行顺序。It should be noted that the execution status indicates: whether the treatment measure information is executed and the execution time. In some embodiments, the execution status may further include the execution order of the treatment measure information.
步骤S905:显示治疗措施集的至少部分治疗措施信息,以及所显示的治疗措施信息中至少部分的执行状态。Step S905: Display at least part of the treatment measure information in the treatment measure set, and the execution status of at least part of the displayed treatment measure information.
在一些具体实施例中,治疗措施集还包括多条治疗措施信息的预设执行顺序;匹配信息还用于指示:与至少一条治疗措施信息相匹配的治疗相关数据与该治疗措施信息的预设执行顺序相匹配或不匹配,执行状态还用于指示治疗措施信息的是否依序执行。In some specific embodiments, the treatment measure set further includes a preset execution order of multiple pieces of treatment measure information; the matching information is further used to indicate: treatment-related data matched with at least one piece of treatment measure information and the preset execution order of the treatment measure information Whether the execution sequence matches or does not match, the execution status is also used to indicate whether the treatment measures information is executed in sequence.
在一些具体实施例中,获取在治疗过程中依序产生的所述目标对象的生理体征信息;生成生理体征数据对应的显示信息,显示信息至少包括波形显示信息;在第二显示界面中的第一显示区域显示生理体征数据对应的显示信息;在第二显示界面中的第二显示区域显示治疗相关数据和治疗相关数据对应的匹配信息。In some specific embodiments, the physiological sign information of the target object generated in sequence during the treatment process is obtained; display information corresponding to the physiological sign data is generated, and the display information at least includes waveform display information; A display area displays display information corresponding to the physiological sign data; a second display area in the second display interface displays treatment-related data and matching information corresponding to the treatment-related data.
在一些具体实施例中,第一显示区域包括时间轴和可移动的游标,在第一显示区域显示时间轴中由游标指向的时间对应的生理体征数据的体征值和治疗相关数据的概况信息,以及在第二显示区域突出显示时间轴中由游标指向的时间对应的治疗相关数据和治疗相关数据对应的匹配信息。In some specific embodiments, the first display area includes a time axis and a movable cursor, and the first display area displays the sign value of the physiological sign data and the overview information of the treatment-related data corresponding to the time pointed by the cursor in the time axis, and the treatment-related data corresponding to the time pointed by the cursor in the time axis and the matching information corresponding to the treatment-related data are highlighted in the second display area.
需要说明的是,上述图9中各个步骤的执行原理,在上文中对监护设备已有详细的描述,在此不再赘述。It should be noted that the execution principle of each step in the above-mentioned FIG. 9 has been described in detail on the monitoring device above, and will not be repeated here.
本领域技术人员可以理解,上述实施方式中各种方法的全部或部分功能可以通过硬件的方式实现,也可以通过计算机程序的方式实现。当上述实施方式中全部或部分功能通过计算机程序的方式实现时,该程序可以存储于一计算机可读存储介质中,存储介质可以包括:只读存储器、随机存储器、磁盘、光盘、硬盘等,通过计算机执行该程序以实现上述功能。例如,将程序存储在设备的存储器中,当通过处理器执行存储器中程序,即可实现上述全部或部分功能。另外,当上述实施方式中全部或部分功能通过计算机程序的方式实现时,该程 序也可以存储在服务器、另一计算机、磁盘、光盘、闪存盘或移动硬盘等存储介质中,通过下载或复制保存到本地设备的存储器中,或对本地设备的系统进行版本更新,当通过处理器执行存储器中的程序时,即可实现上述实施方式中全部或部分功能。Those skilled in the art can understand that all or part of the functions of the various methods in the foregoing embodiments may be implemented by means of hardware or by means of computer programs. When all or part of the functions in the above embodiments are implemented by means of a computer program, the program may be stored in a computer-readable storage medium, and the storage medium may include: read-only memory, random access memory, magnetic disk, optical disk, hard disk, etc. The computer executes the program to realize the above-mentioned functions. For example, the program is stored in the memory of the device, and when the program in the memory is executed by the processor, all or part of the above functions can be realized. In addition, when all or part of the functions in the above-mentioned embodiments are realized by means of a computer program, the program can also be stored in a server, another computer, a magnetic disk, an optical disk, a flash disk or a mobile hard disk and other storage media, and saved by downloading or copying All or part of the functions in the above embodiments can be implemented when the program in the memory is executed by the processor.
以上应用了具体个例对本发明进行阐述,只是用于帮助理解本发明,并不用以限制本发明。对于本发明所属技术领域的技术人员,依据本发明的思想,还可以做出若干简单推演、变形或替换。The above specific examples are used to illustrate the present invention, which are only used to help understand the present invention, and are not intended to limit the present invention. For those skilled in the art to which the present invention pertains, according to the idea of the present invention, several simple deductions, modifications or substitutions can also be made.
Claims (26)
- 一种医疗数据的处理方法,其特征在于,所述方法包括:A method for processing medical data, characterized in that the method comprises:获取与对目标对象开展的治疗过程对应的预设的治疗措施集,所述治疗措施集包括多条治疗措施信息;acquiring a preset treatment measure set corresponding to the treatment process performed on the target object, the treatment measure set including multiple pieces of treatment measure information;获取在治疗过程中依序产生的所述目标对象的治疗相关数据;Obtain the treatment-related data of the target object sequentially generated during the treatment;确定每一所述治疗相关数据与所述治疗措施集中的所述治疗措施信息之间的匹配信息,所述匹配信息指示:所述治疗相关数据与所述治疗措施集中的至少一条治疗措施信息相匹配或不匹配;determining matching information between each of the treatment-related data and the treatment-measure information in the treatment-measure set, the matching information indicating that the treatment-related data is consistent with at least one piece of treatment-measure information in the treatment-measure set match or not match;根据所述匹配信息,确定所述治疗措施集中所述治疗措施信息的执行状态,所述执行状态指示:所述治疗措施信息是否被执行以及执行时间;According to the matching information, determine the execution state of the treatment measure information in the treatment measure set, where the execution state indicates: whether the treatment measure information is executed and the execution time;显示所述治疗措施集的至少部分治疗措施信息及其执行状态。Displaying at least part of the treatment measure information and its execution status of the treatment measure set.
- 根据权利要求1所述的方法,其特征在于,所述治疗措施集还包括所述多条治疗措施信息的预设执行顺序;所述匹配信息还用于指示:与至少一条治疗措施信息相匹配的所述治疗相关数据与该治疗措施信息的预设执行顺序相匹配或不匹配,所述执行状态还用于指示所述治疗措施信息的是否依序执行。The method according to claim 1, wherein the treatment measure set further includes a preset execution order of the plurality of pieces of treatment measure information; the matching information is further used to indicate that it matches with at least one piece of treatment measure information The treatment-related data of , matches or does not match the preset execution order of the treatment measure information, and the execution state is further used to indicate whether the treatment measure information is executed in sequence.
- 根据权利要求1或2所述的方法,其特征在于,还包括:The method according to claim 1 or 2, further comprising:获取在治疗过程中依序产生的所述目标对象的生理体征信息;Obtain the physiological sign information of the target object sequentially generated during the treatment process;按照所述治疗相关数据和所述生理体征数据产生的时间先后顺序,显示所述治疗相关数据、所述治疗相关数据对应的匹配信息和所述生理体征数据。The treatment-related data, the matching information corresponding to the treatment-related data, and the physiological sign data are displayed according to the time sequence in which the treatment-related data and the physiological sign data are generated.
- 根据权利要求3所述的方法,其特征在于,显示所述治疗相关数据、所述治疗相关数据对应的匹配信息和所述生理体征数据,包括:The method according to claim 3, wherein displaying the treatment-related data, matching information corresponding to the treatment-related data, and the physiological sign data, comprises:生成所述生理体征数据对应的显示信息,所述显示信息至少包括波形显示信息;generating display information corresponding to the physiological sign data, where the display information at least includes waveform display information;在第一显示区域显示所述生理体征数据对应的显示信息;Display the display information corresponding to the physiological sign data in the first display area;在第二显示区域显示所述治疗相关数据和所述治疗相关数据对应的匹配信息。The treatment-related data and matching information corresponding to the treatment-related data are displayed in the second display area.
- 根据权利要求4所述的方法,其特征在于,所述第一显示区域包括时间轴和可移动的游标,在所述第一显示区域显示所述时间轴中由所述游标指向 的时间对应的所述生理体征数据的体征值和所述治疗相关数据的概况信息,以及在所述第二显示区域突出显示所述时间轴中由所述游标指向的时间对应的所述治疗相关数据和所述治疗相关数据对应的匹配信息。The method according to claim 4, wherein the first display area includes a time axis and a movable cursor, and the first display area displays the time corresponding to the time pointed by the cursor in the time axis. The physical sign value of the physiological sign data and the overview information of the treatment-related data, and the treatment-related data and the treatment-related data corresponding to the time pointed by the cursor in the time axis are highlighted in the second display area. Matching information corresponding to treatment-related data.
- 根据权利要求1或2所述的方法,其特征在于,所述治疗措施集包括:指定版本的治疗指南中的治疗措施信息,和/或,用户对治疗指南中的治疗措施信息进行调整形成的自定义治疗措施信息。The method according to claim 1 or 2, wherein the treatment measure set comprises: treatment measure information in a treatment guideline of a specified version, and/or formed by adjusting the treatment measure information in the treatment guideline by a user Customize treatment information.
- 根据权利要求1或2所述的方法,其特征在于,还包括:The method according to claim 1 or 2, further comprising:根据操作用户提交的密码信息和/或用户身份信息,确定所述操作用户是否具备治疗措施集的操作权限;According to the password information and/or user identity information submitted by the operating user, determine whether the operating user has the operating authority for the treatment set;若所述操作用户具备所述治疗措施集的操作权限,响应于所述操作用户的操作,设置所述治疗措施集的内容。If the operation user has the operation authority of the treatment measure set, the content of the treatment measure set is set in response to the operation of the operation user.
- 根据权利要求1或2所述的方法,其特征在于,所述治疗相关数据至少包括以下的至少之一:用药事件、实际执行的治疗措施、所述目标对象的诊断结果和所述目标对象的生化检查结果。The method according to claim 1 or 2, wherein the treatment-related data includes at least one of the following: medication events, actually performed treatment measures, the diagnosis results of the target object, and the target object's Biochemical test results.
- 根据权利要求1或2所述的方法,其特征在于,所述确定每一所述治疗相关数据与所述治疗措施集中的所述治疗措施信息之间的匹配信息之前,还包括:The method according to claim 1 or 2, characterized in that before determining the matching information between each of the treatment-related data and the treatment measure information in the treatment measure set, the method further comprises:获取所述治疗相关数据的实际产生时间。The actual generation time of the treatment-related data is obtained.
- 根据权利要求1或2所述的方法,其特征在于,所述确定每一所述治疗相关数据与所述治疗措施集中的所述治疗措施信息之间的匹配信息之前,还包括:The method according to claim 1 or 2, characterized in that before determining the matching information between each of the treatment-related data and the treatment measure information in the treatment measure set, the method further comprises:提取所述治疗相关数据中的关键信息。Extract key information from the treatment-related data.
- 一种监护设备,其特征在于,所述设备包括:A monitoring device, characterized in that the device comprises:存储器,存储与对目标对象开展的治疗过程对应的预设的治疗措施集,所述治疗措施集包括多条治疗措施信息;a memory, storing a preset treatment measure set corresponding to the treatment process performed on the target object, the treatment measure set including a plurality of pieces of treatment measure information;显示器;monitor;处理器,所述处理器配置用于执行下列步骤:a processor configured to perform the following steps:从所述存储器中获取所述治疗措施集,并通过所述显示器显示所获取的所述治疗措施集的至少部分治疗措施信息;Acquire the treatment measure set from the memory, and display at least part of the treatment measure information of the obtained treatment measure set through the display;获取在治疗过程中依序产生的所述目标对象的治疗相关数据;Obtain the treatment-related data of the target object sequentially generated during the treatment;根据所述治疗相关数据,确定所述治疗措施集中的所述治疗措施信息的执行状态,所述执行状态指示:所述治疗措施信息是否被执行以及执行时间;According to the treatment-related data, determine the execution state of the treatment measure information in the treatment measure set, where the execution state indicates: whether the treatment measure information is executed and the execution time;通过所述显示器显示所述治疗措施信息的执行状态。The execution status of the treatment measure information is displayed through the display.
- 根据权利要求11所述的设备,其特征在于,所述处理器还配置用于执行下列步骤:The apparatus of claim 11, wherein the processor is further configured to perform the following steps:确定每一所述治疗相关数据与所述治疗措施集中的所述治疗措施信息之间的匹配信息,并将所述匹配信息存储至所述存储器中,所述匹配信息指示:所述治疗相关数据与所述治疗措施集中的至少一条治疗措施信息相匹配,或所述治疗相关数据与所述治疗措施集中的任一条治疗措施信息不匹配。determining matching information between each of the treatment-related data and the treatment-measure information in the treatment-measure set, and storing the matching information in the memory, the matching information indicating: the treatment-related data Matches with at least one piece of treatment measure information in the treatment measure set, or the treatment-related data does not match any piece of treatment measure information in the treatment measure set.
- 根据权利要求11所述的设备,其特征在于,所述治疗措施集还包括由所述多条治疗措施信息按预设执行顺序执行可形成的治疗措施序列,所述处理器还配置用于执行下列步骤:The device according to claim 11, wherein the treatment measure set further comprises a treatment measure sequence that can be formed by executing the plurality of pieces of treatment measure information in a preset execution order, and the processor is further configured to execute The following steps:确定每一所述治疗相关数据与所述治疗措施集中的治疗措施序列之间的匹配信息,并将所述匹配信息存储至所述存储器中;所述匹配信息指示:所述治疗相关数据与所述治疗措施集中的治疗措施信息是否匹配,以及所述治疗相关数据对应的执行时间是否符合所述治疗措施信息的预设执行顺序。determining matching information between each of the treatment-related data and the treatment-measure sequence in the treatment-measure set, and storing the matching information in the memory; the matching information indicates that the treatment-related data is the same as the treatment-measure sequence. Whether the treatment measure information in the treatment measure set matches, and whether the execution time corresponding to the treatment-related data conforms to the preset execution order of the treatment measure information.
- 根据权利要求11至13任一项所述的设备,其特征在于,所述处理器还配置用于执行下列步骤:The device according to any one of claims 11 to 13, wherein the processor is further configured to perform the following steps:通过所述显示器,按照所述治疗相关数据产生的时间先后顺序,显示所述治疗相关数据、或者显示所述治疗相关数据以及所述治疗相关数据对应的匹配信息。Through the display, the treatment-related data is displayed, or the treatment-related data and matching information corresponding to the treatment-related data are displayed according to the chronological sequence of the treatment-related data.
- 根据权利要求11至13任一项所述的设备,其特征在于,所述处理器配置用于执行下列步骤:The apparatus of any one of claims 11 to 13, wherein the processor is configured to perform the following steps:获取在治疗过程中依序产生的所述目标对象的生理体征数据;acquiring the physiological sign data of the target object sequentially generated during the treatment;生成所述生理体征数据对应的显示信息,所述显示信息至少包括波形显示信息;generating display information corresponding to the physiological sign data, where the display information at least includes waveform display information;通过所述显示器,在第一显示区域显示所述生理体征数据对应的显示信息;Display the display information corresponding to the physiological sign data in the first display area through the display;在第二显示区域显示所述治疗相关数据、或者显示所述治疗相关数据和所述治疗相关数据对应的匹配信息。The treatment-related data is displayed in the second display area, or matching information corresponding to the treatment-related data and the treatment-related data is displayed.
- 根据权利要求15所述的设备,其特征在于,所述第一显示区域包括时间轴和可移动的游标,在所述第一显示区域显示所述时间轴中由所述游标指向的时间对应的所述生理体征数据的体征值和所述治疗相关数据的概况信息,以及在所述第二显示区域突出显示所述时间轴中由所述游标指向的时间对应的所述治疗相关数据和所述治疗相关数据对应的匹配信息。The device according to claim 15, wherein the first display area includes a time axis and a movable cursor, and the first display area displays the time corresponding to the time pointed by the cursor in the time axis. The physical sign value of the physiological sign data and the overview information of the treatment-related data, and the treatment-related data and the treatment-related data corresponding to the time pointed by the cursor in the time axis are highlighted in the second display area. Matching information corresponding to treatment-related data.
- 根据权利要求15所述的设备,其特征在于,在所述第一显示区域的所述时间轴上显示用于指示存在所述治疗相关数据的治疗事件图标,并在所述时间轴上显示所述游标指向的所述治疗事件图标所对应的所述治疗相关数据的概况信息,以及在所述第二显示区域突出显示所述游标指向的所述治疗事件图标所对应的所述治疗相关数据、或者所述治疗相关数据和所述治疗相关数据对应的匹配信息。The device according to claim 15, wherein a treatment event icon for indicating the existence of the treatment-related data is displayed on the time axis of the first display area, and the time axis is displayed on the time axis. overview information of the treatment-related data corresponding to the treatment event icon pointed to by the cursor, and highlighting the treatment-related data corresponding to the treatment event icon pointed to by the cursor in the second display area, Or the treatment-related data and matching information corresponding to the treatment-related data.
- 根据权利要求11所述的设备,其特征在于,所述治疗措施集包括与特定病症关联的集束化治疗措施集,所述处理器还配置用于执行下列步骤:12. The apparatus of claim 11, wherein the set of therapeutic measures comprises a set of bundled therapeutic measures associated with a particular condition, and wherein the processor is further configured to perform the following steps:通过所述显示器显示所述集束化治疗措施集的至少部分治疗措施信息;displaying at least part of the treatment measure information of the bundled treatment measure set through the display;根据所述治疗相关数据标记所述集束化治疗措施集中已被执行的治疗措施信息,并显示已被执行的治疗措施集的执行时间。The information of the treatment measures that have been executed in the bundled treatment measure set is marked according to the treatment-related data, and the execution time of the executed treatment measure set is displayed.
- 根据权利要求18所述的设备,其特征在于,所述治疗措施集还包括与所述特定病症关联的辅助治疗措施集,所述辅助治疗措施集包括无预设执行顺序的多条治疗措施信息;所述处理器还配置用于执行下列步骤:The device according to claim 18, wherein the treatment measure set further comprises an auxiliary treatment measure set associated with the specific condition, the auxiliary treatment measure set including a plurality of pieces of treatment measure information without a preset execution order ; the processor is further configured to perform the following steps:显示至少部分的所述辅助治疗措施集,并根据所述治疗相关数据,标识已被执行的治疗措施信息的执行状态和执行时间。Displaying at least part of the set of auxiliary treatment measures, and identifying the execution status and execution time of the information of the treatment measures that have been executed according to the treatment-related data.
- 根据权利要求18所述的设备,其特征在于,所述集束化治疗措施集包括不同时间版本的第一集束化治疗措施集和第二集束化治疗措施集,所述第一集束化治疗措施集和第二集束化治疗措施集具有至少部分不同的治疗措施信息;所述处理器还配置用于:接收操作用户对所述第一集束化治疗措施集和第二集束化治疗措施集的选择,并在所述第一显示界面中显示所述操作用户选定的选择结果。The device according to claim 18, wherein the bundled treatment measure set comprises a first bundled treatment measure set and a second bundled treatment measure set of different time versions, the first bundled treatment measure set having treatment action information that is at least partially different from the second bundled treatment action set; the processor is further configured to: receive a selection of the first and second bundled treatment action set by an operating user, and displaying the selection result selected by the operating user in the first display interface.
- 根据权利要求11至13任一项所述的设备,其特征在于,所述治疗措施集包括:指定版本的治疗指南中的治疗措施信息,和/或,用户对治疗指南中的治疗措施信息进行调整形成的自定义治疗措施信息。The device according to any one of claims 11 to 13, wherein the treatment measure set comprises: treatment measure information in a treatment guideline of a specified version, and/or a user performs an operation on the treatment measure information in the treatment guideline. Adjust the resulting custom treatment information.
- 根据权利要求11至13任一项所述的设备,其特征在于,所述处理器配置用于执行下列步骤:The apparatus of any one of claims 11 to 13, wherein the processor is configured to perform the following steps:根据操作用户提交的密码信息和/或用户身份信息,确定所述操作用户是否具备治疗措施集的操作权限;According to the password information and/or user identity information submitted by the operating user, determine whether the operating user has the operating authority for the treatment set;若所述操作用户具备所述治疗措施集的操作权限,响应于所述操作用户的操作,设置所述治疗措施集的内容。If the operation user has the operation authority of the treatment measure set, the content of the treatment measure set is set in response to the operation of the operation user.
- 根据权利要求11至13任一项所述的设备,其特征在于,所述治疗相关数据至少包括以下的至少之一:用药事件、实际执行的治疗措施、所述目标对象的诊断结果和所述目标对象的生化检查结果。The device according to any one of claims 11 to 13, wherein the treatment-related data at least includes at least one of the following: medication events, actually performed treatment measures, diagnosis results of the target object, and the Biochemical examination results of the target subject.
- 根据权利要求11至13任一项所述的设备,其特征在于,所述处理器还配置用于执行下列步骤:The device according to any one of claims 11 to 13, wherein the processor is further configured to perform the following steps:获取所述治疗相关数据的实际产生时间。The actual generation time of the treatment-related data is obtained.
- 根据权利要求11至13任一项所述的设备,其特征在于,所述处理器还配置用于执行下列步骤:The device according to any one of claims 11 to 13, wherein the processor is further configured to perform the following steps:提取所述治疗相关数据中的关键信息。Extract key information from the treatment-related data.
- 一种非易失性计算机可读存储介质,其上存储有计算机程序,其特征在于,所述计算机程序被处理器执行时实现如权利要求1至权利要求10中任一所述的医疗数据的处理方法的步骤。A non-volatile computer-readable storage medium on which a computer program is stored, characterized in that, when the computer program is executed by a processor, the processing of medical data according to any one of claims 1 to 10 is realized. The steps of the processing method.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202180073669.1A CN116456891A (en) | 2020-12-25 | 2021-12-23 | Medical data processing method and monitoring equipment |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011563790 | 2020-12-25 | ||
CN202011563790.6 | 2020-12-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022135521A1 true WO2022135521A1 (en) | 2022-06-30 |
Family
ID=82157419
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2021/140825 WO2022135521A1 (en) | 2020-12-25 | 2021-12-23 | Medical data processing method and monitoring equipment |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN116456891A (en) |
WO (1) | WO2022135521A1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110275051A1 (en) * | 2010-05-06 | 2011-11-10 | Ai Cure Technologies Llc | Apparatus and method for recognition of patient activities when obtaining protocol adherence data |
US20150302174A1 (en) * | 2014-04-18 | 2015-10-22 | Sina Fateh | Method and apparatus for verifying therapuetic compliance |
CN106778002A (en) * | 2016-12-26 | 2017-05-31 | 中国科学院苏州生物医学工程技术研究所 | A kind of medical information querying method, equipment and system |
CN110517764A (en) * | 2019-08-28 | 2019-11-29 | 首都医科大学 | For providing the Telemedicine System and method of the nursing of coronary heart disease continuity |
CN111223546A (en) * | 2020-02-13 | 2020-06-02 | 曹庆恒 | Method, system and equipment for intelligently auditing treatment scheme |
CN111512382A (en) * | 2017-10-13 | 2020-08-07 | 阿瑞斯贸易股份公司 | Patient care system |
-
2021
- 2021-12-23 WO PCT/CN2021/140825 patent/WO2022135521A1/en active Application Filing
- 2021-12-23 CN CN202180073669.1A patent/CN116456891A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110275051A1 (en) * | 2010-05-06 | 2011-11-10 | Ai Cure Technologies Llc | Apparatus and method for recognition of patient activities when obtaining protocol adherence data |
US20150302174A1 (en) * | 2014-04-18 | 2015-10-22 | Sina Fateh | Method and apparatus for verifying therapuetic compliance |
CN106778002A (en) * | 2016-12-26 | 2017-05-31 | 中国科学院苏州生物医学工程技术研究所 | A kind of medical information querying method, equipment and system |
CN111512382A (en) * | 2017-10-13 | 2020-08-07 | 阿瑞斯贸易股份公司 | Patient care system |
CN110517764A (en) * | 2019-08-28 | 2019-11-29 | 首都医科大学 | For providing the Telemedicine System and method of the nursing of coronary heart disease continuity |
CN111223546A (en) * | 2020-02-13 | 2020-06-02 | 曹庆恒 | Method, system and equipment for intelligently auditing treatment scheme |
Also Published As
Publication number | Publication date |
---|---|
CN116456891A (en) | 2023-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111292821A (en) | Medical diagnosis and treatment system | |
US8548823B2 (en) | Automatically determining ideal treatment plans for complex neuropsychiatric conditions | |
WO2014084294A1 (en) | Medical inspection result display device, method for operating same, and program | |
US20100241453A1 (en) | Method, Apparatus And Computer Program Product For Displaying And Permitting Revision Of A Potential Interaction | |
JP7232240B2 (en) | Contextualized Patient-Specific Representations of Predictive Score Information | |
WO2021151302A1 (en) | Drug quality-control analysis method, apparatus, device, and medium based on machine learning | |
US11037659B2 (en) | Data-enriched electronic healthcare guidelines for analytics, visualization or clinical decision support | |
US20210098089A1 (en) | Method and system for providing patient-condition-check-display | |
CN107710328A (en) | System for providing electrocardiogram (ECG) analysis for electronic medical record (EMR) | |
US20150234992A1 (en) | Clinical decision support | |
US20230028948A1 (en) | Generation of patient-specific content | |
AU2024205829A1 (en) | Medical care assistance device, and operation method and operation program therefor | |
JP2003310557A (en) | Medical care supporting apparatus, medical care supporting method, and medical care support program | |
RU2733114C2 (en) | Method for generating descriptive reports from executable clinical protocols | |
JP5778730B2 (en) | Medical information display control apparatus, method and program | |
JP2004185547A (en) | Medical data analysis system and medical data analyzing method | |
CN109215800B (en) | Method and device for recording medical advice execution conditions | |
JP7330099B2 (en) | Time Sensitive Risk Model Calculation | |
US20100054555A1 (en) | Systems and methods for use of image recognition for hanging protocol determination | |
WO2022135521A1 (en) | Medical data processing method and monitoring equipment | |
US20160055321A1 (en) | Systems and methods for tooth charting | |
CN115376519A (en) | Method and equipment for generating electronic medical record and computer readable storage medium | |
CN114064764A (en) | Medical multi-data display method, system, device and storage medium | |
JP2013069111A (en) | Information processor and program | |
Kamboj et al. | Predicting Blood Pressure After Nitroglycerin Infusion Dose Titration in Critical Care Units: A Multicenter Retrospective Study |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21909516 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 202180073669.1 Country of ref document: CN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21909516 Country of ref document: EP Kind code of ref document: A1 |